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Abstract
We consider variable selection in competing risks regression for multi-center
data. Our research is motivated by deceased donor kidney transplants, from
which recipients would experience graft failure, death with functioning graft
(DWFG), or graft survival. The occurrence of DWFG precludes graft failure
from happening and therefore is a competing risk. Data within a transplant
center may be correlated due to a latent center effect, such as varying patient
populations, surgical techniques, and patient management. The proportional
subdistribution hazard (PSH) model has been frequently used in the regression
analysis of competing risks data. Two of its extensions, the stratified and the
marginal PSH models, can be applied to multi-center data to account for the
center effect. In this paper, we propose penalization strategies for the two mod-
els, primarily to select important variables and estimate their effects whereas
correlations within centers serve as a nuisance. Simulations demonstrate good
performance and computational efficiency for the proposed methods. It is fur-
ther assessed using an analysis of data from the United Network of Organ
Sharing.
1 Introduction
Kidney transplant is the most cost-effective therapy for patients with end-stage renal
disease, prolonging survival and improving quality of life. This practice is undergoing
a tremendous shortage of organs. As of September, 2015, over 100,000 patients are on
the waiting list in the United States (OPTN/SRTR, 2011). From 2004 to 2014, the
annual number of kidney transplants barely changed, ranging from 16,000 to 17,000
(OPTN/SRTR, 2011), which is greatly disproportionate to the demand. Expanded
donor criteria kidneys from older and sicker donors are being procured as a reaction
to the shortage, which has led to greater discard rates of donated kidneys as well as
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more complications for recipients, including shorter graft survival (Port et al., 2002).
Proper allocation of kidneys is more important than ever.
The Organ Procurement and Transplantation Network (OPTN) approved a new
national deceased donor kidney allocation policy in 2013 in reaction to this short-
age, which prioritizes candidates with longer estimated life expectancy to receive
kidneys with the potential to function longer. The Kidney Donor Risk Index (KDRI)
(Rao et al., 2009) was adopted to measure graft survival of deceased donor kidneys.
Graft survival is defined as the time from the day of transplantation to the earliest
onset of graft failure or death. A lower KDRI is associated with longer graft survival.
This index includes 10 donor factors, which are identified by a variable selection
procedure that sequentially eliminates insignificant factors.
Two complications are present when the primary interest is to specifically predict
the risk of graft failure, as opposed to the composite risk of graft failure and death
as in the KDRI, using multi-center data. One is the presence of competing risks.
After kidney transplantations, recipients may experience graft survival, graft failure,
or death with functioning graft (DWFG). Those who have died with a functioning
graft can no longer develop graft failure. DWFG is therefore a competing risk to
graft failure. The other complication is the center effect arising from available data
of deceased donor kidney transplants. The data were collected by an ongoing or-
gan transplant registry of the United Network of Organ Sharing (UNOS) from all
transplant centers in the US. Patients within a center may have correlated outcomes
due to a latent center effect, such as surgical techniques, patient management, and
patient characteristics (Evans et al., 1991; Kim et al., 2004; Taylor et al., 1985). We
therefore propose penalized variable selection strategies that account for the presence
of competing risks and the center effect. Selected factors can be used to construct
prognostic models for predicting the risk of graft failure.
In competing risks regression, the proportional subdistribution hazard (PSH)
model (Fine and Gray, 1999) has become popular for its direct assessment of co-
variate effects on the cumulative incidence function. Some of its extensions can
account for within-center correlations. Katsahian et al. (2006) and Christian et al.
(2015) proposed a PSH frailty model treating the center effect as a random sam-
ple from a distribution. Ha et al. (2014a) extended this model to handle potential
heterogeneity in the treatment effect among centers. Zhou et al. (2011) developed a
stratified approach to account for varying patient populations by assuming an un-
specified center-specific baseline subdistribution hazard. Zhou et al. (2012) proposed
a marginal PSH model to estimate effects of covariates on the marginal cumulative
incidence function under a working independence assumption; the variance estimator
was adjusted to accommodate the within-center correlations.
Several variable selection methods have been extended to the competing risks set-
ting. Kuk and Varadhan (2013) extended stepwise selection to the PSH model, by
developing selection criteria based on Akaike Information Criteria (AIC), Bayesian
Information Criteria (BIC) and a modified BIC for competing risks data (BICcr). Al-
though simple and easy to use, stepwise selection is computationally intensive and un-
stable, and its theoretical properties are largely unknown (Fan and Li, 2001; Fu et al.,
2015). Fu et al. (2015) developed a generalized penalized variable selection method-
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ology for the PSH model and established the asymptotic properties for the penalized
estimator. However, the stepwise selection and the penalized PSH model cannot ac-
count for the center effect. Ha et al. (2014b) proposed a variable selection procedure
that penalizes a hierarchical likelihood of the PSH frailty model. Their method as-
sumes frailties follow a log-normal distribution and simultaneously perform variable
selection and estimation of covariate effects and frailties. Efficiency in standard errors
is gained if the distribution of frailties is approximately true (O’Quigley and Stare,
2002), but potentially misleading if misspecified. If the study interest only lies in vari-
able selection and estimation of covariate effects, introducing parameters to explicitly
model center effects either through indicator variables or frailties does not seem to
be worthwhile, because it complicates the analysis of covariates effects and may be
subject to numerical difficulties or bias under violations of model assumptions.
In this paper, we propose to extend the penalized variable selection method
(Fu et al., 2015) to the stratified and the marginal PSH models, treating within-
center correlations as a nuisance. The method for the stratified PSH model can be
applied to data exhibiting two types of stratification regimes: the regularly strati-
fied and the highly stratified. The former has a small number of large centers and
the latter has a large number of small centers. Center effects are modeled through
center-specific subdistribution hazards. The method for the marginal PSH model is
suitable for data with a large number of centers. The proposed variance estimator
accommodates the correlation within centers. We also briefly describe the extension
of the proposed methods to group variable selection, which can select pre-specified
groups of variables collectively.
The remainder of this paper is organized as follows. In Section 2, we present the
proposed penalization methods and address implementation issues. In Section 3, sim-
ulations are conducted to evaluate the performance of the proposed methods. Section
4 applies the methods to the data from the UNOS. Section 5 contains discussion.
2 Penalized Variable Selection for Multi-center Com-
peting Risks Data
2.1 Notation
Suppose there are K centers with nk patients for center k, k = 1, . . . , K. The
total number of observations is ΣKk=1nk = n. Cause 1 of failure is graft failure
and cause 2 is the competing risk, DWFG. For patient i within center k, denote
the failure time, the censoring time, and the failure cause as Tki, Cki, and ǫki ∈
{1, 2}. Let Zki = {Z1ki, . . . , Zdki} be a d × 1 vector of covariates. We observe
{Xki, δki, δkiǫki,Zki, ξki}, where Xki =min(Tki, Cki), δki = I(Tki ≤ Cki) is the event
indicator, and ξki ∈ {1, . . . , K} is a center indicator.
Let Tk be a vector of (Tk1, . . . , Tknk)
T , and ǫk, Ck, and Zk are defined similarly.
We assume that (Tk, ǫk,Ck,Zk) are independent and identically distributed; (Tk, ǫk)
and Ck are independent given Zk. Patients within center k are assumed to be exposed
to a common center effect, which implies components of (Tk, ǫk) may be correlated
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conditional on Zk.
2.2 Penalized Stratified PSH Model
2.2.1 Model
The stratified PSH model (Zhou et al., 2011) is a conditional (or center-specific) ap-
proach that models the subdistribution hazards for graft failure in each center sepa-
rately. It can be regarded as an analogy of the stratified Cox model for the competing
risks setting. For center k, the cumulative incidence function for graft failure is defined
as F1k(t;Zki) = Pr(Tki ≤ t, ǫki = 1|Zki, ξki = k). The corresponding subdistribution
hazard is λ1k(t;Zki) = dF1k(t;Zki)/{1− F1k(t;Zki)}. Assuming proportional subdis-
tributional hazards, λ1k(t;Zki) can be written as
λ1k(t;Zki) = λ1k0(t) exp(β
TZki), (1)
where λ1k0(t) is an unspecified center-specific baseline subdistribution hazard, and β
is a d × 1 vector of regression coefficients. Within-center correlation arises from all
patients being exposed to a common center effect.
The log-partial likelihood function is a linear combination of the likelihood for
every center and is defined as
lS(β) =
K∑
k=1
lk(β)
=
K∑
k=1
nk∑
i=1
δkiI(ǫki = 1){βTZki − log
nk∑
i′=1
wˆki′(Xki)Yki′(Xki) exp(β
TZki′)},
(2)
where lk(β) is the log-partial likelihood for center k, Yki(t) = 1− I(Tki ≤ t−, ǫki = 1)
indicates whether the patient is still at risk of graft failure, and wˆki(t) is a time-
dependent weight for patient i within center k. Under the two stratification regimes,
wˆki(t) is defined differently using the inverse probability of censoring weighting tech-
niques (Robins and Rotnitzky, 1992; Zhou et al., 2011) to achieve unbiased estima-
tion. For regularly stratified data, observations are assumed to be i.i.d. within centers
and the censoring distribution is center-dependent. In this case, the weight is defined
as wˆki(t) = I(Cki ≥ Tki ∧ t)Gˆk(t)/Gˆk(Xki ∧ t), where Gk(t) = Pr(Cki ≥ t), i =
1, . . . , nk, and Gˆk(.) is the Kaplan-Meier estimator of Gk(.). It is possible to estimate
Gk(.) from a Cox model by including some potentially important covariates on the cen-
soring. For highly stratified data, observations and censoring are assumed to be i.i.d.
across centers, leading to a weight of wˆki(t) = I(Cki ≥ Tki ∧ t)Gˆ(t)/Gˆ(Xki ∧ t), where
G(t) = Pr(Cki ≥ t) is the common censoring distribution, i = 1, . . . , nk, k = 1, . . . , K.
By time t, if a patient has not experienced any event, wˆki(t)Yki(t) = 1; if the patient
is right censored or has experienced graft failure, wˆki(t)Yki(t) = 0; if the patient
has experienced DWFG, wˆki(t)Yki(t) = Gˆk(t)/Gˆk(Xki) or Gˆ(t)/Gˆ(Xki) ranging from
0 to 1. Covariate effects are estimated through maximizing function (2) and rela-
tive risks obtained from the covariates compare two patients within the same center
(Glidden and Vittinghoff, 2004).
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To perform variable selection and parameter estimation simultaneously, we use a
penalized partial likelihood for the model in equation (1), which is defined as
QS(β) =
K∑
k=1
{lk(β)− nk
d∑
j=1
pλ(|βj|)} = lS(β)− n
d∑
j=1
pλ(|βj|), (3)
where pλ(|βj|) is a penalty function with tuning parameter λ, controlling the complex-
ity of selected models. A larger λ tends to choose a simpler model with fewer selected
variables. Function (3) is essentially penalizing the log-partial likelihood of the ordi-
nary PSH model for every center, and the center-specific penalty is nk
∑d
j=1 pλ(|βj |).
The penalized estimator, denoted as β˜
S
, is the maximizer of the objective function
(3),
β˜
S
= argmaxQS(β).
Since the proportional hazard specification is conditional on centers, λ1k0(t) has
“summed out” in lk(β). The objective function Q
S(β) does not contain the center-
specific baseline subdistribution hazards, which incorporate the center effect. Thus,
the estimation of β˜
S
is not changed by the center effect.
Various penalty functions have been proposed in other settings; see Fan and Lv
(2010) for an extensive review. We consider four popular penalties in this paper, but
our results can be extended to other penalties:
(a). Least Absolute Shrinkage and Selection Operator (LASSO) (Tibshirani, 1996):
pλ(|βj|) = λ|βj|.
(b). Adaptive LASSO (ALASSO) (Zou, 2006): pλ(|βj|) = λθj |βj|, where θj is a data-
adaptive weight assigned to βj . We use θj = |βˆSj |−1, where βˆ
S
is the maximizer
of the log-partial likelihood function.
(c). Smoothly Clipped Absolute Deviation (SCAD) (Fan and Li, 2001): p′λ(|βj|, α) =
λI(|βj| ≤ λ) + (αλ−|βj |)+(α−1) I(|βj| > λ) and α > 2 is a tuning parameter and (x)+
indicates the positive part of x.
(d). Minimax Concave Penalty (MCP) (Zhang, 2010): p′λ(|βj|, γ) = (λ − |βj|γ )+ and
γ > 1 is a tuning parameter.
For the ordinary PSH model, Fu et al. (2015) showed the large sample properties
of ALASSO, SCAD, and MCP, including selection consistency and the oracle prop-
erties, namely, properties of an ideal selection procedure that can work as well as the
underlying model were known in advance (Fan and Li, 2001). When stratification
is added, we can also demonstrate the consistency and the oracle properties of the
three penalties under both stratification regimes: when data are regularly stratified,
the number of center is finite and the center size goes to infinity; when data are
highly stratified, the number of centers goes to infinity whereas the center size holds
finite. Theorems stating the large sample properties of β˜
S
and proofs are included in
Appendix A.
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2.2.2 Implementation Issues
The coordinate descent (CD) algorithm (Friedman et al., 2010; Simon et al., 2011)
and the local quadratic approximation (LQA) algorithm (Fan and Li, 2001, 2002) are
two implementation methods for penalization methods with convex or non-convex
penalties. The former has gained more popularity than the latter for its computational
efficiency (Fan and Lv, 2010). To penalize the stratified PSH model, we use the LQA
algorithm because the CD algorithm may not perform well when the center size is
small.
Two complications arise when applying the CD algorithm to the penalized strati-
fied PSH model with small sizes of centers. First, one step in the CD algorithm is to
approximate the objective function by a penalized least square and the optimization
problem becomes minimizing QS(β) ≈ n−1∑Kk=1(yk − ηk)T (−∂2lk/∂ηk∂ηTk )(yk −
ηk) +
∑d
j=1 pλ(|βj|), where ηk = Zkβ, Zk is the design matrix for stratum k and
yk = ηk − (∂2lk/∂ηk∂ηTk )−1 (∂lk/∂ηk). When the center size is small, the event of
interest within a center is often rare. Inverting the nk × nk matrix ∂2lk/∂ηk∂ηTk may
not be computationally feasible, resulting in the failure of the CD algorithm. For
example, three patients in center k have graft failure, DWFG, and loss to follow-up
sequentially, then ∂2lk/∂ηk∂η
T
k is not positive definite, thus can not be inverted. Sec-
ond, when the inversion is possible, to reduce computational burden, a conventional
method in the CD algorithm is to replace the off-diagonal entries of ∂2lk/∂ηk∂η
T
k by
zeros (Tibshirani, 1996). The replacement works when nk is large, because the off-
diagonals are much smaller than the diagonals (Hastie and Tibshirani, 1999). When
nk is moderate to small, the inverted matrix may not be accurate, potentially leading
to incorrect selection results.
To implement the LQA procedure, we follow Fan and Li (2001, 2002) to locally
approximate the penalty by a quadratic function. Given an initial value β(0) that is
close to β˜
S
, the penalty function pλ(|βj|) is quadratically approximated by
pλ(|βj|) ≈ pλ(|β(0)j |) +
1
2
{p′λ(|β(0)j |)/|β(0)j }{β2j − (β(0)j )2}.
Define the score function US(β) = ∂lS(β)/∂β and the Hessian matrix HS(β) =
∂lS(β)/∂β∂βT . We then apply the Newton-Raphson algorithm to maximize the
objective function (3). At iteration k + 1, the solution is updated by
β(k+1) = β(k) − {HS(β(k))− nAλ(β(k))}−1{US(β(k))− nβ(k)Aλ(β(k))}, (4)
where Aλ(β) is a diagonal matrix with entires Aj =
p′λ(|βj|)
|βj| , j = 1, . . . , d. To avoid
numerical difficulties when βj = 0 , we take the strategy from Hunter and Li (2005)
and employ Aj,ǫ =
p′λ(|βj|)
|βj |+ ǫ , where ǫ is a small positive value such as 10
−6. From equa-
tion (4), standard errors for non-zero penalized estimators can be directly obtained
using the sandwich formula,
ˆcov(β˜
S
1 ) = {HS(β˜
S
1 )− nAλ(β˜
S
1 )}−1 ˆcov{US(β˜
S
1 )}{HS(β˜
S
1 )− nAλ(β˜
S
1 )}−1.
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The explicit formula of ˆcov{US(β˜S1 )} can be found in Zhou et al. (2011).
We employ the Bayesian Information Criteria (BIC) as in Wang et al. (2007) to
select tuning parameters: BIC(λ) = −2lS(β˜S)+log(n)DFλ, where DFλ is the effective
number of parameters and can be computed by tr[{HS(β˜S) − nAλ(β˜S)}−1HS(β˜S)].
The optimum λ minimizes BIC(λ). For SCAD and MCP, we also need to select values
of α and γ. A two-dimensional grid search is usually conducted to find the best pair of
(λ, α) or (λ, γ), but computation can be extensive. Fan and Li (2001) suggested to fix
α ≈ 3.7 for SCAD from a Bayesian statistical point of view. Zhang (2010) suggested
to fix γ ≈ 2.7 for MCP. For simplicity, we use their suggested values throughout this
paper.
2.3 Penalized Marginal PSH Model
Different from the penalization strategy in Section (2.2), which identifies impor-
tant variables for the cumulative incidence function of graft failure conditional on
transplant centers, the primary interest of the penalized marginal PSH model is the
marginal cumulative incidence function. The standard error of regression coefficients
is then corrected for within-center correlations. The marginal cumulative incidence
function is defined as F1(t;Zki) = P (Tki ≤ t, ǫki = 1|Zki), i = 1, . . . , nk, k = 1, . . . , K,
and the marginal subdistribution hazard can be defined accordingly: u1(t;Zki) =
dF1(t;Zki)/{1−F1(t;Zki)}. Zhou et al. (2012) proposed to model u1(t;Zki) with the
proportional hazard specification, u1(t;Zki) = u10(t) exp(β
TZki), where µ10(t) is an
unspecified baseline shared by all centers and β has a population-average interpreta-
tion. Relative risk of a factor compares two patients who are randomly selected from
the population (Wei et al., 1989). The marginal PSH model can be regarded as an
analogy of the marginal Cox model proposed by Lee et al. (1992) for the competing
risks setting, and it is suitable when the scientific interest is on the study population.
Maximizing the marginal partial likelihood is usually prohibitive in terms of com-
putation. Zhou et al. (2012) proposed a pseudo-partial likelihood function as an
alternative to the full likelihood by assuming that event times of graft failure are
independent of each other even if they belong to the same center. The log-pseudo-
partial likelihood function is defined as follows
lM(β) =
K∑
k=1
nk∑
i=1
δkiI(ǫki = 1){βTZki−
log
K∑
k′=1
nk∑
i′=1
wˆk′i′(Xk′i′)Yk′i′(Xk′i′) exp(β
TZk′i′)},
(5)
where wˆki(t) is a marginal inverse probability of censoring weight and is defined
as wˆki(t) = I(Cki ≥ Tki ∧ t)Gˆ(t)/Gˆ(Xki ∧ t), i = 1, . . . , nk, k = 1, . . . , K. Note
the formulation of the log-pseudo-partial likelihood function is the same as the log-
partial likelihood for the ordinary PSH model. Maximizing this likelihood function is
computationally advantageous and the estimated regression coefficients are consistent
and asymptotically normal (Zhou et al., 2012). Denote the maximizer of function (5)
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as βˆ
M
. The variance estimator of βˆ
M
is adjusted for the within-center correlations
(Zhou et al., 2012).
To identify important variables for the marginal cumulative incidence function,
we propose to penalized the log-pseudo-partial likelihood function. The objective
function is defined as
QM(β) = lM (β)−K
d∑
j=1
pλ(|βj|). (6)
The penalized estimator maximizes the objective function (6) and is denoted as
β˜
M
= argmaxQM(β).
The marginal PSH model regards center as the sampling unit, we hence formulate
the objective function (6) with a scale of K for the penalty term. With such a
formulation, we are able to show selection consistency and the oracle properties of
ALASSO, SCAD, and MCP as K → ∞. The theorem and proofs are included in
Appendix B.
The efficient CD algorithm can be employed to optimize the objective function (6),
because in the penalized marginal PSH model, this algorithm minimizes QM(β) ≈
K−1(y − η)T (−∂2lM/∂η∂ηT )(y − η) +∑dj=1 pλ(|βj|), where η = Zβ, Z is the n ×
d design matrix, and y = η − (∂2lM/∂η∂ηT )−1(∂lM/∂η). For a data set with a
moderate sample size, the n × n matrix ∂2lM/∂η∂ηT is positive definite and thus
can be inverted. Since QM(β) differs from the objective function of the penalized
PSH model only by the scale of the penalty term, we follow the implementation
procedure presented in Fu et al. (2015) with adjusted penalty terms. The tuning
parameter can be selected by BIC(λ) = −2lM(β˜M ) + log(K)DFλ, where DFλ =
tr{Z(ZT DˆMZ −KAλ)−1ZT DˆM} and DˆM is a diagonal matrix with entries of hki =
∂2lM/∂ηki∂η
T
ki|β=β˜M , i = 1, . . . , nk, k = 1, . . . , K.
Center effects (or within-center correlations) are accommodated in the variance-
covariance estimator of β˜
M
, which is defined as
ˆcov(β˜
M
) = {ZT DˆMZ−KAλ(β˜M)}−1 ˆcov(UM(β˜M)){ZT DˆMZ−KAλ(β˜M)}−1,
where UM (β) is the score function of lM(β) accommodating the within-center cor-
relations. Since we assume event times are independent, UM(β) is equivalent to
the score function of the ordinary PSH model. However, the standard covariance of
UM(β) proposed by Fine and Gray (1999) may no longer be valid due to the possi-
ble dependence among patients within a center (Lee et al., 1992; Zhou et al., 2012).
Zhou et al. (2012) showed that UM(β) is asymptotically equivalent to a sum of inde-
pendent identically distributed random variables. Therefore, the covariance ofUM(β)
can be consistently estimated, in a manner robust to the within-cluster correlations.
The explicit expression of ˆcov{UM(β)} can be found in Zhou et al. (2012).
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2.4 Extension to Group Variable Selection
Among the potential risk factors for graft failure, some have multiple categories and
can be represented by a group of dummy variables. For example, the mismatch score
of human leukocyte antigen B (HLA-B) has three levels (0, 1, and 2) and the peak
panel reactive antibody is categorized into four levels (=0, 1-50, 51-80, >80). The
selection of such factors corresponds to the selection of groups of variables. Our
methods can be easily adapted to group variable selection by adjusting the penalty
function.
Assume there are J groups of variables and each group is of size dj, j = 1, . . . , J .
The vector of regression coefficients can be divided into J sub-vectors, βT = (βT1 , . . . ,β
T
J ).
We replace the penalty functions in objective functions (3, 6) with their group ver-
sion, p(‖βj‖; d1/2j λ), where ‖βj‖ = (βTj βj)1/2 and dj is a scalar for adjusting group
sizes, j = 1, . . . , J . The case d1 = . . . ,= dJ = 1 denotes individual variable selection.
Following Fu et al. (2015), the penalized estimators with group penalties are expected
to behave similarly to their individual versions and optimization procedures can be
developed accordingly.
3 Simulation
Three sets of simulations are conducted to assess the performance of the penal-
ized stratified PSH model (‘penalized stratified model’ hereafter) and the penalized
marginal PSH model (‘penalized marginal model’ hereafter). Results on the maxi-
mum partial likelihood estimator (MPLE) and the oracle estimators are also reported.
Here the oracle estimator is obtained by fitting the underlying model. In the first
simulation, the number of centers is fixed at three and the center size is relatively
large. The performance of the penalized stratified model for regular stratification is
evaluated. The penalized marginal method is not assessed due to the small number
of centers. In the second set, the center number is large while the center size is small.
The performance of the penalized stratified model for high stratification and the pe-
nalized marginal model is evaluated. In the third set, both the number of centers and
the center size are moderate. The performance of the penalized stratified model for
regular and high stratification as well as the penalized marginal model is assessed.
In the first two sets of simulations, we also applied the penalized PSH model with
log-normal frailties (‘penalized frailty model’ hereafter) (Ha et al., 2014b) and com-
pare its performance with the penalized stratified model. The penalized frailty model
is a conditional approach that models the center effect through frailties. For center
k, the subdistribution hazard conditional on frailties v1 = (v11, . . . , v1k, . . . , v1K) has
the following form
λ1k(t;Zki, v1k) = λ10(t)v1k exp(β
T
1Zki), (7)
where v1 has two assumptions: (1) v1 follows a log-normal distribution and (2) v1
acts proportionally on the baseline subdistribution hazard. Through penalizing the
model in equation (7), Ha et al. (2014b) demonstrated that the model performs well
through simulations where both assumptions on v1 are satisfied. In our simulations,
9
we show the limitation of the penalized frailty model due to its restrictive assumptions,
and also demonstrate the flexibility of the penalized stratified model, which does not
require explicit modeling of the center effect.
The performance of variable selection methods is assessed by four measures: the
average numbers of correctly (C) and incorrectly (IC) selected zero coefficients, the
percentage of identifying the true model (Pcorr), and the median of mean squared
error (MMSE). Values of C and IC characterize the performance in shrinking unim-
portant variables to zero and selecting important variables respectively. The mean
squared error (MSE) is defined as (β˜
S −β0)I(β˜
S −β0) or (β˜
M −β0)I(β˜
M −β0) for
assessing the model error, where I is the population correlation matrix (Tibshirani,
1997) .
3.1 A Small Number of Large Centers
In this scenario, the center indicator ξ is randomly sampled from {1, 2, 3}. For each
center, we follow the procedure described in Fine and Gray (1999) to simulate data.
Eight covariates Z1, . . . , Z8 are included in the model, and they are marginally stan-
dard normal with pairwise correlations corr(Zi, Zj) = ρ
|i−j|, where ρ = 0.5. For cause
1, the vector of regression coefficients is β1 = (0.8, 0, 0, 1, 0, 0, 0.6, 0)
T , implying that
the underlying model includes Z1, Z4, and Z7. For cause 2, the regression parameter
is β2 = −β1. The baseline subdistribution hazards for the three centers have different
parametric forms and their cumulative incidence functions for cause 1 are defined as
follows
F11(t;Z1i) = 1− {1− p× Φ(log(t)− 1
0.25
)}exp(βT1 Z1i),
F21(t;Z2i) = 1− [1− p{1− exp(−0.018et + 0.018)}]exp(βT1 Z2i),
F31(t;Z3i) = 1− [1− p{1− exp(−t5)}]exp(βT1 Z3i),
which are a log-normal mixture, a Gompertz mixture, and a Weibull mixture with
mass 1−p at∞ when Zki = 0. The value of p is 0.6. Their corresponding cumulative
incidence functions conditional on cause 2 follow exponential distributions with rates
5 exp(βT2Z1i), 10 exp(β
T
2Z2i), and 2 exp(β
T
2Z3i)}. Censoring times are independently
generated from a Uniform (0, 9) distribution to achieve a censoring rate of 25%−30%.
Note under this setting, the penalized frailty model may not perform well due to the
restrictive form of the subdistribution hazard. According to the model in equation
(7), baseline subdistribution hazards of the three centers only differ by the scalar v1k,
while the ones in our scenario have distinct shapes.
Table 1 shows the selection results of the penalization methods for the regularly
stratified PSH model and the PSH frailty model with sample sizes of 200 and 400.
All penalties outperform the MPLE. In particular, the performance of ALASSO,
SCAD, and MCP in identifying the underlying model and parameter estimation is
close to the oracle estimator. LASSO tends to select over-fitted models with higher
false positive rates than the other three penalties. Regardless of penalty choices,
the penalized frailty model tends to select unimportant variables while dropping the
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Table 1: Selection results of the penalized stratified and frailty model based on
100 replications with p = 0.6. Center number K = 3. Sample size n = 200 and
400. The censoring rate is 28% and the event rate is 40%.
n=200 n=400
Penalty Model C IC Pcorr MMSE C IC Pcorr MMSE
MPLE Stratified 0 0 0% 0.133 0 0 0% 0.060
Frailty 0 0 0% 0.280 0 0 0% 0.219
LASSO Stratified 3.37 0 23% 0.112 3.76 0 29% 0.055
Frailty 3.50 0.05 23% 0.228 3.78 0 32% 0.180
ALASSO Stratified 4.75 0.01 79% 0.064 4.92 0 92% 0.028
Frailty 4.57 0.08 69% 0.159 4.77 0 83% 0.118
SCAD Stratified 4.92 0 92% 0.052 4.93 0 93% 0.027
Frailty 4.74 0.12 81% 0.100 4.85 0 86% 0.100
MCP Stratified 4.92 0 92% 0.056 4.93 0 93% 0.026
Frailty 4.76 0.12 84% 0.098 4.85 0 86% 0.100
Oracle Stratified 5 0 100% 0.044 5 0 100% 0.021
Frailty 5 0 100% 0.095 5 0 100% 0.092
C: the average number of coefficients that are correctly set to zero; IC: the average number
of coefficients that are incorrectly set to zero; Pcorr: the percentage of identifying the true
model; MMSE: median of mean squared error.
important ones. Its model error is twice the error of the penalized stratified model
when n = 200 and five times the error when n = 400.
3.2 A Large Number of Small Centers
In this scenario, center numbers are 100 and 200. The center size is either 2 or
uniformly sampled from {2, 3, 4, 5}. For center k, we consider a conditional subdistri-
bution hazard in the form of the frailty model, λ1k(t;Zki, v1k) = λ10(t)v1k exp(β
T
1Zki),
where λ10(t) = e
−t and v1k is generated from a positive stable distribution with
parameter α1. A smaller α1 is associated with a higher within-center correlation,
implying that patients within a center are more similar. Under this setting, the as-
sumption that v1k follows a log-normal distribution in the penalized frailty model is
violated. Covariates Z1, . . . , Z8 are marginally standard normal with pairwise cor-
relations ρ|i−j|, where ρ = 0.5. The cumulative incidence function conditional on
frailties and covariates is F1k(t;Zki, v1k) = 1 − exp{e−tv1k exp(βT1Zki)}. Given cause
2, the conditional cumulative incidence function is assumed to be exponential with a
rate of v2k exp(β
T
2Zki), where β2 = −β1. The frailty v2k is generated from a positive
stable distribution with parameter α2. Data are then simulated based on the two
conditional cumulative incidence functions.
From the conditional cumulative incidence function, we can derive the marginal
cumulative incidence function and the marginal subdistribution hazard by integrating
out the frailties. The resulting marginal subdistribution hazard also satisfies the
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Table 2: Selection results of the penalized stratified and frailty model based on 100
replications for α1 = 0.4 and 0.7. Center number K = 100 and 200. Center size
nk = 2 and nk ∈ {2, 3, 4, 5}. The censoring rate is 27% and the event rate is 46%.
Numbers in the parentheses are ratios of MMSE of the penalized estimator to the
oracle estimator.
Stratified Frailty
α1 = 0.4 α1 = 0.7 α = 0.7
nk K penalty C IC Pcorr MMSE C IC Pcorr MMSE(ratio) C IC Pcorr MMSE(ratio)
2 100 MPLE 0 0 0% 1.184 0 0 0% 1.160 (2.86) 0 0 0% 0.176 (2.63)
LASSO 3.93 0.41 29% 0.616 3.76 0.38 30% 0.557 (1.37) 3.12 0.02 15% 0.195 (2.92)
ALASSO 4.45 0.61 46% 0.494 4.42 0.50 47% 0.541 (1.33) 4.27 0.06 49% 0.125 (1.87)
SCAD 4.36 0.81 46% 0.940 4.53 0.81 43% 0.964 (2.37) 4.60 0.09 69% 0.093 (1.40)
MCP 4.19 0.68 44% 0.986 4.52 0.80 42% 0.964 (2.37) 4.60 0.08 69% 0.102 (1.52)
Oracle 5 0 100% 0.283 5 0 100% 0.406 (1.00) 5 0 100% 0.067 (1.00)
200 MPLE 0 0 0% 0.365 0 0 0% 0.406 (3.09) 0 0 0% 0.098 (2.18)
LASSO 3.58 0.08 22% 0.307 3.54 0.03 17% 0.320 (2.44) 3.34 0 20% 0.116 (2.58)
ALASSO 4.60 0.18 57% 0.226 4.58 0.18 59% 0.241 (1.84) 4.69 0 76% 0.075 (1.67)
SCAD 4.79 0.35 71% 0.218 4.83 0.34 69% 0.287 (2.18) 4.76 0 81% 0.060 (1.34)
MCP 4.79 0.36 72% 0.218 4.82 0.33 69% 0.280 (2.13) 4.76 0 81% 0.060 (1.34)
Oracle 5 0 100% 0.102 5 0 100% 0.131 (1.00) 5 0 100% 0.045 (1.00)
{2,3,4,5} 100 MPLE 0 0 0% 0.169 0 0 0% 0.164 (2.80) 0 0 0% 0.085 (2.75)
LASSO 3.66 0 20% 0.161 3.61 0 22% 0.178 (3.04) 3.34 0 19% 0.100 (3.23)
ALASSO 4.70 0.05 72% 0.104 4.76 0.02 79% 0.097 (1.65) 4.58 0 68% 0.058 (1.89)
SCAD 4.86 0.06 86% 0.060 4.90 0.06 88% 0.060 (1.02) 4.70 0 75% 0.051 (1.63)
MCP 4.87 0.06 87% 0.060 4.90 0.05 87% 0.060 (1.02) 4.70 0 75% 0.051 (1.63)
Oracle 5 0 100% 0.049 5 0 100% 0.058 (1.00) 5 0 100% 0.031 (1.00)
200 MPLE 0 0 0% 0.075 0 0 0% 0.078 (2.47) 0 0 0% 0.042 (2.45)
LASSO 3.49 0 23% 0.087 3.76 0 29% 0.080 (2.55) 3.44 0 18% 0.047 (2.77)
ALASSO 4.85 0 87% 0.038 4.82 0 84% 0.041 (1.29) 4.72 0 79% 0.024 (1.42)
SCAD 4.94 0 94% 0.030 4.92 0 93% 0.034 (1.08) 4.76 0 79% 0.022 (1.31)
MCP 4.94 0 94% 0.030 4.92 0 93% 0.034 (1.08) 4.78 0 80% 0.022 (1.27)
Oracle 5 0 100% 0.028 5 0 100% 0.032 (1.00) 5 0 100% 0.017 (1.00)
Notation is the same as Table 1.
proportional hazard assumption (Zhou et al., 2012; Logan et al., 2011). By Laplace
transformation,
F1(t;Zki) =
∫ t
0
F1(u;Zki, v1k)dFV1k(u) = 1− exp{−Mα10 (t)e(β
∗
1)
T
Zki}, (8)
u1(t;Zki) = α1M
α1−1
0 (t)λ10(t) exp{(β∗1)TZki}, (9)
where M0(t) =
∫ t
0
λ10(s)ds, and β
∗
1 = α1β1. Correspondingly, the marginal cumula-
tive incidence function given cause 2 is exponential with rate α2t
α2−1 exp{(β∗2)TZki}
and β∗2 = α2β2.
Table 2 summarizes the selection results of the penalization method for the highly
stratified PSH model and the PSH frailty model, where β1 = (0.8, 0, 0, 1, 0, 0, 0.6, 0)
and α1 = α2 = 0.4 or 0.7. The penalized frailty model is only applied for α1 = 0.7,
because when α1 = 0.4, the algorithm can not converge under the mis-specification
of the frailty distribution. We additionally include relative MMSE, which is defined
as the ratio of the MMSE of the penalized estimator to the oracle estimator.
Overall, the performance of the penalized stratified model is improved as the
sample size increases, but invariant to the change of within-center correlations. When
the center size is 2 such as in the matched cohort study, error rates of identifying
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important variables and model errors are much higher than the oracle estimator.
Because a center only contributes to the partial likelihood when the failure from
the cause of interest is observed for a subject while the other subject has not failed
from any causes or has already failed from the competing risks, a great amount of
information is discarded, leading to the worsened performance. As the center size
increases to {2, 3, 4, 5}, the accuracy in model selection and parameter estimation is
considerably improved. SCAD and MCP consistently beat the other penalties and
perform similarly to the oracle estimator in all scenarios.
Comparing the penalized stratified and the penalized frailty models for α1 = 0.7,
the former outperforms the latter in eliminating unimportant variables and producing
small relative MMSEs when the center size is in {2, 3, 4, 5}, but underperforms when
the center size is two. Note that the penalized frailty model has smaller absolute
MMSEs than the penalized stratified model for all penalties, MPLE, and the oracle
estimator. It is possible that the parametric modeling of frailties using the log-
normal distribution can roughly capture the positive stable distribution, leading to
less variation in penalized estimators than the penalized stratified model.
Table 3 shows the simulation results for the penalized marginal PSH model with
β∗1 = (0.8, 0, 0, 1, 0, 0, 0.6, 0)
T and α1 = α2 = 0.4 or 0.7. For both center sizes, the
performance is similar. As the number of centers increases, the accuracy of variable
selection and parameter estimation is improved. Three penalties, ALASSO, SCAD,
and MCP have close performance to the oracle estimator for K = 200. When the
within-center correlation is larger (α1 = 0.4), selected models have less correctly
selected zeros and higher model errors versus when the correlation is smaller (α1 =
0.7), but the difference is minor.
It should be noted that the penalized stratified model and the penalized marginal
model were applied to data that were simulated using different regression parameters
( i.e., β1). In the simulations for the penalized stratified model, data were simulated
based on the center-specific subdistribution hazard λ1k(t; zki, v1k) = λ10(t)v1k exp(β
T
1 zki)
with β1 = (0.8, 0, 0, 1, 0, 0, 0.6)
T . In the simulations for the penalized marginal model,
we set β∗1 = (0.8, 0, 0, 1, 0, 0, 0.6)
T , and data were generated using the center-specific
subdistribution hazard with β1 = α
−1
1 β
∗
1. Since 0 < α1 < 1, β1 is larger than β
∗
1
in magnitude, implying that the covariate effects for the underlying marginal PSH
model is smaller than those for the underlying stratified PSH model. When the pe-
nalized stratified model and the penalized marginal model are applied to the same
data set, the latter is more likely to select a larger model than the former, because
the penalization method tends to select a larger model when the covariate effects are
smaller (Tibshirani, 1997; Zhang and Lu, 2007).
3.3 A Moderate Number of Moderately Sized Centers
We follow Section 3.2 to simulate competing risks data with 50 centers and a center
size of 25 or 50. Table 4 summarizes the selection results of the penalized stratified
models with both regular and high stratification, where β1 = (0.8, 0, 0, 1, 0, 0, 0.6, 0),
α1 = α2 = 0.4 or 0.7. When both the number of center and the center size are
moderate, the performance of the penalized regularly stratified model is similar to
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Table 3: Selection results of the penalized marginal model based on 100 replications
with α1 = 0.4 and 0.7. Center number K = 100 and 200. Center size nk = 2 and
nk ∈ {2, 3, 4, 5}. The censoring rate is 29% and the event rate is 43%.
α1 = 0.4 α1 = 0.7
nk K penalty C IC Pcorr MMSE C IC Pcorr MMSE
2 100 MPLE 0 0 0% 0.166 0 0 0% 0.171
LASSO 3.55 0 26% 0.092 3.39 0 19% 0.130
ALASSO 4.73 0 77% 0.048 4.74 0 79% 0.064
SCAD 4.79 0 82% 0.040 4.83 0 86% 0.054
MCP 4.83 0 85% 0.039 4.80 0 82% 0.054
Oracle 5 0 100% 0.030 5 0 100% 0.044
200 MPLE 0 0 0% 0.076 0 0 0% 0.066
LASSO 3.29 0 19% 0.063 3.50 0 20% 0.069
ALASSO 4.89 0 89% 0.026 4.88 0 90% 0.023
SCAD 4.90 0 92% 0.021 4.92 0 93% 0.017
MCP 4.91 0 92% 0.022 4.89 0 90% 0.018
Oracle 5 0 100% 0.020 5 0 100% 0.016
(2,3,4,5) 100 MPLE 0 0 0% 0.099 0 0 0% 0.097
LASSO 3.38 0 20% 0.066 3.56 0 22% 0.060
ALASSO 4.81 0 87% 0.032 4.84 0 85% 0.035
SCAD 4.80 0 87% 0.031 4.88 0 91% 0.031
MCP 4.81 0 87% 0.030 4.84 0 85% 0.032
Oracle 5 0 100% 0.028 5 0 100% 0.029
200 MPLE 0 0 0% 0.050 0 0 0% 0.039
LASSO 3.48 0 18% 0.036 3.73 0 28% 0.032
ALASSO 4.93 0 93% 0.017 4.95 0 95% 0.016
SCAD 4.97 0 97% 0.015 4.96 0 96% 0.014
MCP 4.95 0 95% 0.016 4.96 0 96% 0.014
Oracle 5 0 100% 0.014 5 0 100% 0.014
Notation is the same as Table 1.
that of the penalized highly stratified model. Similar to the observations in Table
2, the within-center correlation does not affect the performance of the penalized
stratified model. Three penalties, ALASSO, SCAD, and MCP, perform similarly to
the oracle estimator for both nk = 25 and 50, due to the large sample size. Notably,
the performance of ALASSO for the penalized highly stratified model is improved
compared to its performance when the center size is small in Section 3.2. Because a
larger center contributes more information, the MPLE, i.e. the data-adaptive weights
for the ALASSO, is more accurate.
Table 4 also demonstrates the selection results for the penalized marginal model
with the same settings of center sizes, center numbers, and within-center correlations.
Data were simulated with β∗1 = (0.8, 0, 0, 1, 0, 0, 0.6, 0)
T as in Section 3.2. When the
number of centers is moderate (K = 50), the penalized marginal model performs
worse than the scenario when K = 100 or 200 in Section 3.2.
In the above simulations in Section 3.1-3.3, censoring times were generated inde-
pendently from event times, failure causes, and covariates. When censoring times are
covariate-dependent, the simulation results suggest that the proposed penalization
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methods perform similarly to the situation when censoring times and covariates are
independent. This may be due to the inverse probability of censoring weighting tech-
niques (Robins and Rotnitzky, 1992) used in the stratified PSH model (Zhou et al.,
2011), and the marginal inverse probability of censoring weight applied in the marginal
PSH model (Zhou et al., 2012), which allows possible dependence between covariates
and censoring times (Fine and Gray, 1999). Refer to Appendix D.
Table 4: Selection results of the penalized stratified model based on 100 replications
for α1 = 0.4 and 0.7. Center number K = 50. Center size nk = 25 and 50. The
censoring rate is 26-27% and the event rate is 45-49%.
α = 0.4 α = 0.7
Model K nk C IC Pcorr MMSE C IC Pcorr MMSE
Regularly 50 25 MPLE 0 0 0 0.018 0 0 0 0.017
Stratified LASSO 3.56 0 0.2 0.020 3.67 0 0.22 0.022
ALASSO 4.96 0 0.96 0.007 4.93 0 0.94 0.018
SCAD 4.97 0 0.97 0.005 4.97 0 0.97 0.007
MCP 4.97 0 0.97 0.005 4.97 0 0.97 0.007
Oracle 5 0 1 0.005 5 0 1 0.007
50 MPLE 0 0 0 0.008 0 0 0 0.006
LASSO 3.81 0 0.2 0.009 3.77 0 0.33 0.010
ALASSO 4.95 0 0.95 0.003 4.97 0 0.97 0.004
SCAD 4.98 0 0.98 0.003 4.94 0 0.94 0.004
MCP 4.98 0 0.98 0.003 4.94 0 0.94 0.004
Oracle 5 0 1 0.003 5 0 1 0.004
Highly 50 25 MPLE 0 0 0 0.018 0 0 0 0.017
Stratified LASSO 3.57 0 0.21 0.021 3.67 0 0.23 0.023
ALASSO 4.96 0 0.96 0.007 4.92 0 0.93 0.019
SCAD 4.97 0 0.97 0.005 4.97 0 0.97 0.007
MCP 4.97 0 0.97 0.005 4.97 0 0.97 0.007
Oracle 5 0 1 0.005 5 0 1 0.007
50 MPLE 0 0 0 0.008 0 0 0 0.006
LASSO 3.78 0 0.18 0.010 3.76 0 0.35 0.010
ALASSO 4.95 0 0.95 0.003 4.97 0 0.97 0.004
SCAD 4.98 0 0.98 0.003 4.94 0 0.94 0.004
MCP 4.98 0 0.98 0.003 4.94 0 0.94 0.004
Oracle 5 0 1 0.003 5 0 1 0.004
Marginal 50 25 MPLE 0 0 0 0.033 0 0 0 0.026
LASSO 2.52 0 0 0.025 3.04 0 0.13 0.023
ALASSO 4.76 0 0.81 0.017 4.86 0 0.87 0.011
SCAD 4.70 0 0.83 0.016 4.71 0 0.85 0.013
MCP 4.75 0 0.83 0.018 4.75 0 0.84 0.013
Oracle 5 0 1 0.014 5 0 1 0.010
50 MPLE 0 0 0 0.025 0 0 0 0.018
LASSO 2.60 0 0 0.018 3.39 0 0.15 0.014
ALASSO 4.77 0 0.82 0.016 4.85 0 0.88 0.010
SCAD 4.69 0 0.84 0.016 4.77 0 0.88 0.012
MCP 4.76 0 0.84 0.017 4.85 0 0.88 0.010
Oracle 5 0 1 0.013 5 0 1 0.008
Notation is the same as Table 1.
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4 Application
In the KDRI study, a subset of UNOS data was used (Rao et al., 2009), including pa-
tients who received deceased donor kidney transplants in 1995-2005 with the following
exclusion criteria: recipients with previous transplants, with multi-organ transplants,
ABO-incompatible, with missing/invalid donor height, with missing/invalid donor
weight, or with missing/invalid donor creatinine. Patients were followed from the
time of transplantation until the earliest onset of graft failure, DWFG, loss to follow-
up, or the conclusion of the observation period (May 1, 2006). A stratified Cox
model adjusting for the transplant center effect was fitted and a composite endpoint
including graft failure and DWFG was fitted.
We use the UNOS data maintaining the same exclusion criteria, but with longer
follow-up time. Patients were followed through March 21, 2013, which incorporates
more follow-up information than the KDRI study. We only include patients with
complete information on relevant variables. A total of 33,690 patients from 256
centers were obtained, among whom, 10,357 (31%) had graft failures, 7,936 (24%)
died with a functioning graft, and 15,397 (46%) were censored. The median number
of patients per center is 98.
Thirty-four potential risk factors from the KDRI study are considered in the ini-
tial model. Donor factors include donor age, race, sex, height, weight, cause of death,
donation after cardiac death, serum creatinine, diabetes status, hypertension status,
cigarette users, hepatitis C virus (HCV) positivity. Transplant factors include cold
ischemia time, organ sharing (local, regional, national), human leukocyte antigen B
(HLA-B) mismatch score (0, 1, 2), HLA-DR mismatch score (0, 1, 2), en bloc trans-
plant, double transplant, and ABO compatibility. Recipient factors include recipient
age, race, sex, height, weight, primary diagnosis (glomerulonephritis, diabetes, hy-
pertension, failed transplants, congenital anomalies of the kidney and urinary tract
(CAKUT), others), diabetes status, pre-transplant blood transfusion, peak panel re-
active antibody (PRA) level (=0, 1-50, 51-80, >80), years of renal replacement ther-
apy (RRT) (≤1, 2-3, >3), angina pectoris, peripheral vascular disease (PVD), drug-
treated chronic obstructive pulmonary disease (COPD), and HCV positivity. Two
continuous variables, donor’s age and serum creatinine, have nonlinear relationship
with the outcome (Rao et al., 2009), we categorize them into three and two levels
respectively as in the KDRI study. Hence, grouping structures exist in donor age,
peak PRA, serum creatinine, organ sharing, HLA-B and HLA-DR mismatch score,
years of RRT, and primary diagnosis. Thirteen extra variables are added. The initial
model therefore includes 47 variables.
To account for the center effect and the competing risk, we fit the penalized
stratified and the penalized marginal models with four penalties: LASSO, ALASSO,
SCAD, and MCP. Grouped variables are selected in or out together. Since the center
number and the center size are both large, we consider both the regularly and the
highly stratified PSH models. Table 5 presents selected donor and transplant fac-
tors and corresponding estimated coefficients. Standard errors are included in the
parenthesis. Refer to Appendix C for complete selection results.
16
Table 5: Variable selection results and estimated regression coefficients using UNOS data. Standard errors are in the parenthesis.
Regularly Stratified Highly Stratified Marginal
LASSO ALASSO SCAD MCP LASSO ALASSO SCAD MCP LASSO ALASSO SCAD MCP
Donor Factors
Age -40 yrs 0.012 (0.001) 0.013 (0.001) 0.013 (0.001) 0.012 (0.001) 0.011 (0.001) 0.013 (0.001) 0.013 (0.001) 0.012 (0.001) 0.012 (0.001) 0.013 (0.001) 0.012 (0.001) 0.012(0.001)
(applies to all ages)
Age -18 yrs -0.010 (0.008) -0.013 (0.006) -0.005 (0.007) -0.005 (0.007) -0.015 (0.006) -0.014 (0.005) -0.005 (0.005) -0.005 (0.005) -0.014 (0.008) -0.018 (0.007) -0.014 (0.008) -0.014 (0.008)
(applies only if age<18)
Age -50 yrs 0.020 (0.003) 0.018 (0.003) 0.018 (0.003) 0.019 (0.003) 0.018 (0.003) 0.016 (0.002) 0.018 (0.002) 0.019 (0.002) 0.020 (0.003) 0.018 (0.003) 0.020 (0.003) 0.020 (0.003)
(applies only if age>50)
Afrian American race 0.170 (0.031) 0.167 (0.031) 0.172 (0.031) 0.168 (0.031) 0.151 (0.023) 0.148 (0.027) 0.174 (0.026) 0.169 (0.027) 0.164 (0.033) 0.157 (0.033) 0.166 (0.033) 0.166 (0.033)
Male -0.037 (0.026) - - - -0.042 (0.018) - - - -0.035 (0.026) -0.027 (0.023) -0.034 (0.026) -0.034 (0.026)
Height: per 10 cm increase -0.021 (0.013) -0.031 (0.011) -0.029 (0.011) -0.008 (0.01) -0.031 (0.008) -0.028 (0.009) -0.018 (0.014) - -0.019 (0.014) -0.019 (0.014)
Weight -0.227 (0.06) -0.311 (0.052) -0.248 (0.059) -0.241 (0.059) -0.169 (0.048) -0.215 (0.043) -0.251 (0.05) -0.244 (0.045) -0.213 (0.064) -0.235 (0.059) -0.220 (0.064) -0.22 (0.064)
(per 5 kg increase if <80 kg)
Donation after cardiac death - - - - - - - - - - - -
Cause of death: stroke 0.061 (0.025) 0.073 (0.024) - 0.067 (0.024) 0.067 (0.021) 0.040 (0.019) 0.069 (0.022) 0.066 (0.025) 0.053 (0.025) 0.066 (0.025) 0.066 (0.025)
Serum creatinine-1 0.195 (0.036) 0.174 (0.035) 0.183 (0.035) 0.186 (0.035) 0.150 (0.026) 0.107 (0.028) 0.183 (0.022) 0.187 (0.029) 0.192 (0.035) 0.155 (0.035) 0.196 (0.035) 0.196 (0.035)
(applies to all Cr values )
Serum creatinine-1 -0.189 (0.05) -0.165 (0.049) -0.176 (0.049) -0.179 (0.049) -0.143 (0.034) -0.099 (0.036) -0.177 (0.032) -0.180 (0.036) -0.185 (0.046) -0.148 (0.046) -0.189 (0.046) -0.189 (0.046)
(applies if Cr>1.5 )
Diabetic 0.233 (0.047) 0.237 (0.047) 0.228 (0.047) 0.232 (0.047) 0.212 (0.039) 0.191 (0.038) 0.231 (0.034) 0.235 (0.036) 0.242 (0.05) 0.229 (0.049) 0.245 (0.05) 0.245 (0.05)
Hypertensive 0.137 (0.026) 0.139 (0.026) 0.151 (0.026) 0.138 (0.026) 0.132 (0.02) 0.130 (0.021) 0.150 (0.018) 0.136 (0.022) 0.142 (0.027) 0.143 (0.027) 0.142 (0.027) 0.142 (0.027)
Cigarette users 0.027 (0.021) - - - 0.017 (0.013) - - - 0.024 (0.018) - 0.025 (0.018) 0.025 (0.018)
Positive HCV status 0.098 (0.068) - - - 0.070 (0.048) - - - 0.133 (0.064) 0.055 (0.064) 0.135 (0.064) 0.135 (0.064)
Transplant Factors
Cold ischemic time 0.003 (0.001) - - - 0.002 (0.001) - - - 0.004 (0.002) 0.002 (0.001) 0.004 (0.002) 0.004 (0.002)
(ref=20 hr)
Organ sharing (ref=local)
Regional 0.061 (0.037) - - - 0.045 (0.022) - - - 0.030 (0.038) - 0.031 (0.038) 0.031 (0.038)
National -0.052 (0.031) - - - -0.038 (0.027) - - - -0.049 (0.037) - -0.051 (0.037) -0.051 (0.037)
HLA-B mismatch
0 (ref=2 B MM) -0.155 (0.034) -0.176 (0.031) -0.174 (0.031) -0.174 (0.031) -0.141 (0.028) -0.134 (0.025) -0.174 (0.027) -0.174 (0.03) -0.154 (0.039) -0.158 (0.039) -0.156 (0.039) -0.156 (0.039)
1 -0.068 (0.023) -0.070 (0.023) -0.069 (0.023) -0.069 (0.023) -0.057 (0.019) -0.051 (0.021) -0.067 (0.018) -0.067 (0.017) -0.055 (0.025) -0.052 (0.024) -0.056 (0.025) -0.056 (0.025)
HLA-DR mismatch
0 (ref=1 DR MM) -0.097 (0.027) -0.103 (0.027) -0.102 (0.027) -0.102 (0.027) -0.087 (0.024) -0.078 (0.02) -0.102 (0.024) -0.102 (0.023) -0.091 (0.03) -0.084 (0.029) -0.092 (0.03) -0.092 (0.03)
2 0.055 (0.023) 0.057 (0.023) 0.058(0.023) 0.057 (0.023) 0.051 (0.018) 0.047 (0.019) 0.058 (0.017) 0.057 (0.02) 0.063 (0.025) 0.058 (0.025) 0.063 (0.025) 0.063 (0.025)
Transplant year -0.155 (0.021) -0.161 (0.021) -0.165 (0.021) -0.163 (0.021) -0.139 (0.018) -0.139 (0.021) -0.166 (0.02) -0.164 (0.02) -0.151 (0.025) -0.156 (0.025) -0.152 (0.025) -0.151 (0.025)
en bloc transplant -0.313 (0.117) -0.285 (0.116) -0.317 (0.117) -0.312 (0.117) -0.209 (0.094) -0.083 (0.085) -0.310 (0.094) -0.304 (0.081) -0.295 (0.124) -0.132 (0.122) -0.304 (0.124) -0.304 (0.124)
Double kidney transplant -0.334 (0.093) -0.329 (0.092) -0.332 (0.092) -0.330 (0.092) -0.247 (0.063) -0.181 (0.047) -0.331 (0.067) -0.330 (0.061) -0.329 (0.078) -0.250 (0.078) -0.338 (0.078) -0.338 (0.078)
ABO identical - - - - - - - - -0.023 (0.052) - -0.026 (0.052) -0.027 (0.052)
Cr: serum creatinine. HLA: human leukocyte antigen.
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For the penalized stratified model, the regularly and the highly stratified select
the same variables, with slight differences in estimated effects of covariates. The three
oracle penalties, ALASSO, SCAD, and MCP, select similar models, in which 16 out
of 18-19 factors are selected by all of them. LASSO selects 27 factors, producing
larger models than the others. The penalized marginal model selects larger models
than the penalized stratified model, suggesting that the factors that are significant
for the marginal cumulative incidence function may not necessarily have effects on
the center-specific cumulative incidence function. Across penalties, LASSO, SCAD,
and MCP have similar selection results and ALASSO selects a smaller model than
the others.
One can choose between the penalized marginal model and the penalized stratified
model based on study interests. If the study interest is on the study population,
then the penalized marginal model is appropriate, because patients are considered
as a representative random sample from the kidney transplant population, and the
effects of selected factors have a population-average interpretation (Lee and Nelder,
2004). Alternatively, the penalized stratified model can be applied to account for the
varying patient populations across centers. In our analysis, the stratified approach
was adopted as in the KDRI study.
The prognostic ability of the selected stratified PSH models in Table 5 can be
assessed by a class of discrimination and calibration methods (Wolbers et al., 2009;
Schoop et al., 2011). The concordance index (C-index) is a measure of discrimina-
tion ranging from 0 to 1 with 1 being perfect discrimination. It is defined as the
proportion of all evaluable ordered patients pairs for which prediction and outcomes
are concordant. Wolbers et al. (2009) adapted this measure to the competing risks
setting and defined an ordered pair as evaluable if the first patient has graft failure
at a time point when the second has not experienced any event or has died with a
functioning graft. An evaluable ordered pair is concordant if the first patient has
higher risk prediction than the second. An alternative measure of discrimination is
the D-index, originally proposed by Royston and Sauerbrei (2004) in standard sur-
vival analysis. The D-index measures the separation of cumulative incidence curves
and can be interpreted as the log-hazard ratio comparing two equal-sized prognostic
groups based on dichotomizing the linear predictor from the fitted model. This index
is non-negative and a larger value suggests greater discrimination ability. Prediction
error (PE) of selected models can be computed as an integrated difference between
the observed and the predicted cumulative incidence functions up to a time point
(Schoop et al., 2011). Using the results from Fibrinogen Studies (2009), we extend
the three measures to the stratified PSH model. The measure of PE is infeasible for
the highly stratified PSH model, because the estimator for the baseline cumulative
subdistribution hazard can not be obtained due to small strata sizes (Zhou et al.,
2011).
We randomly sample 4/5 of the data set as a training set and the rest is a testing
set. For regular stratification, the sampling is conducted within centers. For high
stratification, one center is regarded as one unit and the sampling is performed upon
centers. We obtain parameter estimates using the training set only and then compute
the C-index, the D-index, and the 5-year prediction error for the testing set. The
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Table 6: Prognostic statistics for penalized stratified models. Standard errors are in
the parenthesis.
Stratification Penalty
No.
donor
factors
No.
transplant
factors
C-index D-index 5-year prediction error
Regular LASSO 11 7 0.635 (0.007) 0.846 (0.033) 0.145 (0.004)
ALASSO 7 5 0.636 (0.006) 0.841 (0.036) 0.146 (0.003)
SCAD 7 5 0.635 (0.006) 0.832 (0.033) 0.146 (0.003)
MCP 8 5 0.636 (0.006) 0.842 (0.038) 0.146 (0.004)
High LASSO 11 7 0.636 (0.008) 0.846 (0.037) -
ALASSO 7 6 0.636 (0.008) 0.843 (0.038) -
SCAD 7 5 0.636 (0.008) 0.841 (0.037) -
MCP 8 5 0.636 (0.008) 0.841 (0.037) -
splitting, estimation and prediction are repeated for 100 times. The averages of the
three measures are reported.
Table 6 shows the prognostic statistics for each model. Standard errors are in-
cluded in the parentheses. All models have similar discrimination power and predic-
tion accuracy. ALASSO and MCP have the highest C-index. LASSO has the highest
D-index and the lowest 5-year prediction error. We adopt the regularly stratified PSH
model penalized by MCP, because it has satisfactory prognostic ability and model
parsimony. Although ALASSO and MCP have similar prognostic statistics and the
former has one donor factor (height) less than the latter, it is more reasonable to
include both height and weight in the model, since the two are highly correlated and
patients’ heights can be easily obtained.
Our prognostic model, which we refer to as the kidney donor graft failure index
(KDGFI), can be constructed in the same way as the KDRI, by using the exponential
of the prognostic index (PI). Here PI is a weighted sum of selected donor factors, where
the weights are the estimated regression coefficients. Transplant factors are usually
not included when assessing generic donor quality (Rao et al., 2009). Since baseline
subdistribution hazards are not included, KDGFI is a relative cumulative incidence
or absolute risk for graft failure compared with a reference donor whose KDGFI is
1.00. The reference donor has the following characteristics: 40-year-old, non-African
American race, height 170cm, weight more than or equal to 80 kg, cause of death
other than cerebrovascular accident, serum creatinine 1.0 mg/dL, non-diabetic, and
non-hypertensive. For a particular deceased donor kidney, its PI is calculated by
summing PI components for all applicable donor characteristics, which are listed in
Table 7. The KDGFI is then the exponential of the PI.
All donor factors in KDGFI are also included in the KDRI. These factors have the
same signs but different magnitudes in the two indices. Two KDRI factors, donation
after cardiac death (DCD) and HCV status, are not included the KDGFI. Although
use of DCD kidneys is associated with increased risk of delayed graft function, there is
no significant difference in long-term outcomes between DCD and non-DCD kidneys
(Weber et al., 2002; Snoeijs et al., 2010). This might be the reason that DCD is not
selected. HCV status is not included in the KDGFI, because use of HCV antibody
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Table 7: KDGFI donor characteristics and model coefficients
Donor Characteristics Applies to KDGFI Prognostic Index (PI)
Age (integer years) All donors 0.012×(age-40)
Donor with age <18 -0.005×(age-18)
Donor with age >50 0.019×(age-50)
Height (cm) All donors -0.029×(height-170)/10
Weight (kg) All donors with weight <80 kg -0.241×(weight-80)/5
Ethnicity African American donors 0.168
History of Hypertension Hypertensive donors 0.138
History of Diabetes Diabetic donors 0.232
Cause of Death (COD) Donors with COD=cerebrovascular accident 0.067
Serum Creatinine All donors 0.186×(creat-1)
Donors with creat >1.5mg/dL -0.179 ×(creat-1.5)
positive donor (HCVD+) kidneys does not significantly increase the risk of graft
failure in HCV antibody positive recipients (HCVR+) (Morales et al., 2010), and the
majority of HCVD+ kidneys (77% in the UNOS data) are transplanted to HCVR+.
5 Discussion
In the analysis of kidney transplant data, variable selection procedures are compli-
cated by the presence of within-center correlations and competing risks. To take the
two issues into account, this paper proposes to penalize the stratified and the marginal
PSH models, where primary interests are simultaneous variable selection and param-
eter estimation. Within-center correlations are not explicitly modeled. The penalized
marginal model treats the whole center as one unit and achieves good performance
when the number of centers is large. The penalized stratified model performs well
when either the center size or the center number is large. However, as seen in Table
2 this approach may not be suitable in the analysis of matched data, for which the
center size is 2. By applying the proposed methods to the UNOS data from deceased
donor kidney transplants, we develop the KDGFI comprised of eight donor charac-
teristics for assessing the relative risk of graft failure. Our analysis results offer a new
perspective in quantifying the quality of a kidney organ by considering the competing
risk of DWFG, and provide a useful tool in practical kidney transplant research.
The penalized PSH frailty model can be applied to account for the center effect
when within-center correlations are of genuine interest, but it may not be appealing
in our case where the primary interest is covariate effects. As previously mentioned it
is restrictive regarding the type of dependency encompassed and requires the center
effect to act proportionally on the subdistribution hazard. Additionally, calculation
is cumbersome when the center number is large, due to the involvement of double
iterative procedures (Prentice and Cai, 1992). The first iteration calculates frailties
and the number of parameters to be estimated is the number of centers. The second
iteration conducts the penalization procedure conditional on the frailties. In contrast,
the stratified approach only involves the penalization procedure. In the case of the
KDGFI study, the number of transplant centers is 256. Using the frailty model
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requires extra estimation of 256 parameters, which considerably increases computing
time.
The current study was conducted under the setting where d < K or/and d < nk
for the stratified approach and d < K for the marginal approach, while in many
applications, data may be high-dimensional, for example, d > n, n > d > nk > K, or
n > d > K > nk. Due to the curse of dimensionality, computation may be prohibitive
(Fan and Lv, 2010). The proposed penalization methods may not accurately select
the underlying model, and their theoretical properties may not be valid. Future work
could involve extending the proposed methods to the high-dimensional setting, along
with developing efficient and robust computing procedures.
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Appendix A Large Sample Properties of the Pe-
nalized Stratified PSH Model
For simplicity, we shall work on the finite time interval [0, τ ]. Because of the distinct
asymptotic behaviors of the center number and the center size, we write β˜
S
as β˜
S
r
and β˜
S
h for regularly and highly stratified data respectively. The following conditions
are needed to establish the oracle properties.
A1.
∫ τ
0
λk0(t)dt <∞ for k = 1, . . . , K.
A2. For regularly stratified data, {Nki(.), Yki(.), zki(.)}i=1,...,nk are independently and
identically distributed; For highly stratified data, {Nki(.), Yki(.), zki(.), i = 1, . . . , nk}k=1,...,Kare
independently distributed.
A3. Define
s
(p)
k (β, t) = limnk→∞
n−1k
nk∑
i=1
I(Cki ≥ t)Yki(t)z⊗pki exp(βTzki) (10)
S
(p)
k (β, t) = n
−1
k
nk∑
i=1
I(Cki ≥ t)Yki(t)z⊗pki exp(βTzki) (11)
Sˆ
(p)
k (β, t) = n
−1
k
nk∑
i=1
wˆki(t)Yki(t)z
⊗p
ki exp(β
Tzki) (12)
For regularly stratified data, there exits a neighborhood B of β0 such that the follow-
ing conditions are satisfied: (i) there exits a scalar, a vector, and a matrix function
s
(0)
k , s
(1)
k , and s
(2)
k defined on B×[0, τ ] such that supt∈[0,τ ],β∈B‖S(p)k (β, t)−s(p)k (β, t)‖ →
0 in probability, p = 0, 1, 2; (ii). the matrix Ωk =
∫ τ
0
vk(β0, t)s
(0)
k (β0, t)λ0k(t)dt is
positive definite, where vk = s
(2)
k /s
(0)
k − (s(1)k /s(0)k )(s(1)k /s(0)k )T .
For highly stratified data, the matrix I(β0) = limK→∞K
−1
∑K
k=1 E[
∑nk
i=1
∫ τ
0
{zki −
zk(β0, u)}⊗2S(0)(β0, u)λ0k(u)du is positive definite.
A4. The penalty function satisfies that an = Op(n
−1/2) and bn → 0.
A5. For regular stratified data, pλn(|β|) satisfies lim
nk→∞
√
nk inf
|β|≤Cn−1/2
p′λn(|β|) → ∞, k =
1, . . . , K.
For highly stratified data, pλn(|β|) satisfies lim
K→∞
mK1/2 inf
|β|≤Cn−1/2
p′λn(|β|) → ∞,
where m = lim
K→∞
n/K.
A.1 The Regular Stratified PSH Model
Theorem 1 states selection consistency and the oracle properties for the penalization
methods for the regularly stratified PSH model.
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Theorem 1. For regularly stratified data with finite K, when n→∞, nk →∞. The
following holds under Condition A.1 - A.5,
(a.) β˜
S
r is a root-n consistent estimator for β0, i.e. ||β˜
S
r − β0|| = Op(n−1/2).
(b.) (Oracle properties) With probability tending to 1, the root-n consistent estimator
β˜
S
r satisfies
(i.) (Sparsity) β˜
S
2r = 0
(ii.) (Asymptotic normality) n1/2
∑K
k=1 πk(Ω11k+P){β˜
S
1r−β01+(Ω11k+P)−1b} →
N(0,
∑K
k=1 πkΣ11k), where pk = nk/n → πk, Ω11k and Σ11k are the first
s× s submatrix of Ωk(β0) and Σk(β0), defined in the Appendix.
A.1.1 Proof of Theorem 1.a
To prove β˜
S
r − β0 = Op(n−1/2), it is sufficient to prove that for any positive ǫ, there
exists a large constant C such that
Pr{ sup
‖u‖=C
QS(β0 + αnu) < Q
S(β0)} ≥ 1− ǫ (13)
where αn = n
−1/2+ an. This means with probability at least 1− ǫ, there exits a local
maximum such that ‖β˜Sr − β0‖ = Op(αn).
Denoting Dn(u) =
1
n
{QS(β0 + αnu)−QS(β0)}, we have
Dn(u) ≤ 1
n
K∑
k=1
[
{lk(β0 + αnu)− lk(β0)} − nk
s∑
j=1
{pλn(|βj0 + αnuj|)− pλn(|βj0|)}
]
(14)
=
1
n
K∑
k=1
nkDnk(u) (15)
where Dnk(u) =
1
nk
{lk(β0+αnu)− lk(β0)}−
∑s
j=1{pλn(|βj0+αnuj|)−pλn(|βj0|)} :=
D1 +D2
By Taylor expansion, D1 is
1
nk
{lk(β0 + αnu)− lk(β0)} =
1
nk
(
∂lk(β0)
∂β
)Tαnu− 1
2
uT{− 1
nk
∂2lk(β0)
∂βT∂β
+ op(1)}uα2n
(16)
= Op(n
−1/2
k )αnu−
1
2
α2nu
T {Ωk(β0) + op(1)}u (17)
= Op(Cn
−1/2
k αn) +Op(C
2α2n) (18)
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From Fan and Li (2002), D2 is bounded by
√
sanαn||u|| + bnα2n||u2||, which has the
order of Cα2n if bn → 0. Define rk = nk/n→ πk, which is a finite number between 0
and 1. Summing over K strata,
Dn(u) ≤
K∑
k=1
nk
n
{Op(Cn−1/2k αn) +Op(C2α2n) +Op(Cα2n)} (19)
=
K∑
k=1
rk{Op(Cα2nr−1/2k ) +Op(C2α2n) +Op(Cα2n)} (20)
By choosing a sufficiently large C, Op(C
2α2n) dominates the others. Thus inequal-
ity(13) holds.
A.1.2 Proof of Theorem 1.b. (i)
It is sufficient to show that for any given β1 that is root-n consistent and for any
constant C,
QS(β1, 0) = max
||β2||≤Cn
−1/2
QS(β1,β2) (21)
This is equivalent to show that
∂QS(β)
∂βj
< 0 for 0 < βj < Cn
−1/2, and
∂QS(β)
∂βj
> 0
for −Cn−1/2 < βj < 0 with probability tending to 1 as n→∞, j = s+ 1, . . . , d.
For stratum k, define the following
Xk(β, τ) =
1
nk
{lk(β)− lk(β0)} (22)
=
1
nk
nk∑
i=1
∫ τ
0
{(β − β0)TZki − log
Sˆ
(0)
k (β, u)
Sˆ
(0)
k (β0, u)
}wˆki(u)dNki(u) (23)
Ak(β, τ) =
1
nk
nk∑
i=1
∫ τ
0
{(β − β0)TZki − log
Sˆ
(0)
k (β, u)
Sˆ
(0)
k (β0, u)
}wˆki(u)λ1k(u)du (24)
=
∫ τ
0
{(β − β0)T Sˆ(1)k (β0, u)− Sˆ(0)k (β0, u) log
Sˆ
(0)
k (β, u)
Sˆ
(0)
k (β0, u)
}λ1k0(u)du (25)
From Fine and Gray (1999), Xk(β, .) − Ak(β, .) is a sum of martingale integrals
with respect to locally bounded process. Since limnk→∞ Sˆ
(p)(β, t) = G(t)s
(p)
k (β, t), by
condition 3 it follows that for each β ∈ B,
Ak(β, τ)→ fk(β, τ) =
∫ τ
0
{(β − β0)T s(1)k (β0, u)− s(0)k (β0, u) log
s
(0)
k (β, u)
s
(0)
k (β0, u)
}λ1k0(u)du
(26)
where fk has the following properties
fk(β0) = 0,
∂fk(β0)
∂β
= 0, −∂
2fk(β0)
∂β∂βT
= Ωk(β0) (27)
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Then the following holds
1
nk
{lk(β)− lk(β0)} = fk(β, τ) +Op(
||β − β0||√
nk
) (28)
We also have fk(β) = −1
2
(β − β0)T{Ωk(β0) + o(1)}(β − β0). By Taylor expansion,
we obtain
∂QS(β)
∂βj
=
K∑
k=1
∂lk(β)
∂βj
− nkp′λn(|βj |)sgn(βj) (29)
=
K∑
k=1
nk
d∑
l=1
∂2fk(β0)
∂βj∂βl
(βl − βl0) +Op(nk||β − β0||2)− nkp′λn(|βj|)sgn(βj)
(30)
=
K∑
k=1
Op(nkn
−1/2) +Op(rk)− nkp′λn(|βj|)sgn(βj) (31)
=
K∑
k
n
1/2
k {Op(rk)− n1/2k p′λn(|βj|)sgn(βj)} (32)
Since lim
nk→∞
√
nk inf
||β||≤Cn−1/2
p′λn(|β|) → ∞, k = 1, . . . , K in condition C.2, the sign of
∂QS(β)
βj
is completely determined by the sign of βj .
A.1.3 Proof of Theorem 1.b. (ii)
It is easy to show that there exists a root-n consistent local maximizer β˜
S
r1 of Q(β1, 0),
satisfying equation
∂Q(β)
∂β1
∣∣∣
β=((β˜
S
r1)
T ,0)T
= 0. Denote US(β) and HS(β) as the score
function and the Hessian matrix of lS(β) and they are
US(β) =
K∑
k=1
Uk(β) =
K∑
k=1
nk∑
i=1
∫ ∞
0
{Zik − Sˆ
(1)
i (β, u)
Sˆ
(0)
i (β, u)
}wˆik(u)dNik(u) (33)
HS(β) =
K∑
k=1
Hk(β) =
K∑
k=1
nk∑
i=1
∫ ∞
0
[
Sˆ
(2)
i (β, u)
Sˆ
(0)
i (β, u)
− { Sˆ
(1)
i (β, u)
Sˆ
(0)
i (β, u)
}⊗2
]
wˆik(u)dNik(u)
(34)
For j = 1, . . . , s
0 =
K∑
k=1
∂lk(β)
∂βj
∣∣∣
β=(β˜
T
1 ,0)
T
− nkp′λn(|β˜Srj|)sgn(β˜Srj)
=
K∑
k=1
∂lk(β0)
∂βj
−
s∑
l=1
{−∂
2fk(β0)
∂βj∂βl
+ op(1)}(β˜Srl − βl0)−
nk
(
p′λn(|βj0|)sgn(βj0) + {p′′λn(|βj0|) + op(1)}(β˜Srj − βj0)
)
(35)
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Denote U11k(β) as the first s elements of the score function Uk(β) for stratum k. As
nk →∞, n−1/2k U11k(β0)→ N(0,Σ11k(β0)) in distribution, where Σ11k is the first s×s
submatrix of Σk. Th explicit formula of Σk can be found in Fine and Gray(1999).
Thus n−1/2
∑K
k=1U11k(β0) = n
−1/2
∑K
k=1 r
1/2
k n
−1/2
k U11k(β0) → N(0,Σ11(β0)), where
Σ11 =
∑K
k=1 πkΣ11k. Furthermore, let H11k be the first s× s submatrix of of Hk and
− 1
nk
H11k → Ω11k(β0) in probability, where Ω11k is the first s × s submatrix of Ωk.
Let b1 be the first s elements of b, and P11 be the first s × s submatrix of P. By
Slutsky’s Theorem,
n1/2
K∑
k=1
πk(Ω11k +P11){β˜Sr1 − β01 + (Ω11k +P11k)−1b1} → N(0,Σ11(β0)) (36)
This completes the proof.
A.2 The highly stratified PSH Model
Theorem 2 states selection consistency and the oracle properties of the penalization
methods for the highly stratified PSH model.
Theorem 2. For highly stratified data with finite nk, when n → ∞, K → ∞ . The
following holds under Condition A.1 - A.5,
(a.) β˜
S
h is a root-n consistent estimator for β0, i.e. ||β˜
S
h − β0|| = Op(n−1/2).
(b.) (Oracle properties) With probability tending to 1, the root-n consistent estimator
β˜
S
h satisfies
(i.) (Sparsity) β˜
S
2h = 0
(ii.) (Asymptotic normality) n1/2(Ω11 + P){β˜S1h − β01 + (Ω11 + P)−1b} →
N(0, m−1Σ11(β0)), where m = lim
K→∞
n/K, Ω11 and Σ11 are the first s× s
submatrix of Ω(β0) and Σ(β0), defined in the Appendix.
Following the proof of Theorem 1, we briefly give the proof of Theorem 2.
A.2.1 Proof of Theorem 2.a.
When data are highly-stratified, the strata size nk is finite and K →∞ as n→∞. To
prove the validity of equation (13), we also writeDn(u) =
1
n
{QS(β0+αnu)−QS(β0)},
and
Dn(u) ≤ 1
n
K∑
k=1
{lk(β0 + αnu)− lk(β0)} −
s∑
j=1
{pλn(|βj0 + αnuj|)− pλn(|βj0|)} (37)
:= I1 + I2 (38)
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By Taylor expansion,
I1 =
1
n
K∑
k=1
(
∂lk(β0)
∂β
)Tαnu− 1
2
uT{−1
n
K∑
k=1
∂2lk(β0)
∂βT∂β
+ op(1)}uα2n (39)
= Op(m
−1/2αnC) +Op(α
2
nC
2) (40)
where m = n/K is the average strata size as n → ∞ and is a finite number. From
Section A.1.1, term I2 has the order of Cα
2
n if bn → 0. By choosing a sufficiently large
C, Op(C
2α2n) dominates the others. Thus inequality(13) holds.
A.2.2 Proof of Theorem 2.b. (i)
Following Section A.1.2, we prove equation (21) also holds when data are highly
stratified. Based on the results from Zhou et al. (2001), the following holds
1
K
{lS(β)− lS(β0)} =
1
K
K∑
k=1
[
nk∑
i=1
∫ ∞
0
(β − β0)TZkidNki(u)−
∫ ∞
0
log
S
(0)
k (β, u)
S
(0)
k (β0, u)
dNk(u)
]
+ op(1)
(41)
=
1
K
K∑
k=1
Xk(β) + op(1) (42)
where S
(p)
k (β, u) =
1
nk
∑nk
i=1wik(u)Yik(u)Zik(u)
⊗p exp{βTZik} and dNk(u) =
∑nk
i=1 dNki(u).
Correspondingly,
Xk(β) =
nk∑
i=1
∫ ∞
0
(β − β0)TZkidNki(u)−
∫ ∞
0
log
S
(0)
k (β, u)
S
(0)
k (β0, u)
dNk(u), (43)
χk(β) = E{Xk(β)}, and χ(β) = lim
K→∞
1
K
K∑
k=1
χk(β) (44)
χ(β0) = 0,
∂χ(β0)
∂β
= 0, −∂
2χ(β0)
∂β∂βT
= I(β0) (45)
Because
1
K
∑K
k=1E{|Xk(β) − χk(β)|2} = Op(1), we obtain
1
K
{lS(β) − lS(β0)} =
χ(β) + Op(K
−1/2). Also We also have χ(β) = −1
2
(β − β0)T{I(β0) + o(1)}(β − β0).
By Taylor expansion, we obtain
∂QS(β)
∂βj
=
∂lS(β)
∂βj
− np′λn(|βj |)sgn(βj) (46)
= K
d∑
l=1
∂2χ(β0)
∂βj∂βl
(βl − βl0) +Op(K1/2)− np′λn(|βj|)sgn(βj) (47)
= Op(Kn
−1/2 +K1/2)− np′λn(|βj|)sgn(βj) (48)
= K1/2{Op(m−1/2)−mK1/2p′λn(|βj|)sgn(βj)} (49)
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As lim
K→∞
mK1/2 inf
||β||≤Cn−1/2
p′λn(|β|)→∞ in condition A5, the sign of
∂QS(β)
βj
is com-
pletely determined by the sign of βj .
A.2.3 Proof of Theorem 2.b. (ii)
There exists β˜
S
h1 satisfying equation
∂Q(β)
∂β1
∣∣∣
β=((β˜
S
h1)
T ,0)T
= 0. For j = 1, . . . , s
0 =
∂lS(β)
∂βj
∣∣∣
β=((β˜
S
h1)
T ,0)T
− np′λn(|β˜j|)sgn(β˜Shj)
=
∂lS(β0)
∂βj
−
s∑
l=1
{−∂
2lS(β0)
∂βj∂βl
}(β˜Shl − βl0)− n
(
p′λn(|βj0|)sgn(βj0) + {p′′λn(|βj0|) + op(1)}(β˜Shj − βj0)
)
(50)
Denote USh (β) and H
S
h (β) as the score function and the Hessian matrix for highly
stratified data. The sub-vector USh1(β) is the first element of U
S
h (β), and H
S
h11(β) is
the first s × s matrix of HSh (β). As K → ∞, K−1/2USh1(β0) → N(0,Σ11h(β0)) in
distribution, where Σ11h is the first s× s submatrix of Σh. Details of the matrix Σh
can be found in Zhou et al.(2011). Also −1
n
Hh11 → Ωh11(β0) in probability, and Ωh11
is the first s× s submatrix of Ωh. Here mΩh equals to I defined in condition A3. By
Slutsky’s Theorem,
n1/2(Ω11 +P11){β˜1 − β01 + (Ω11 +P11)−1b1} → N(0, m−1Σ11(β0)) (51)
This completes the proof.
A.3 Oracle Properties of Penalties
Conditions A.4 and A.5 provide guidance to select penalties that will have the oracle
properties in the stratified PSH model. With a proper choice of λ, we show that
ALASSO, SCAD, and MCP satisfy the two conditions.
(a). ALASSO: since Zhou et al. (2011) have shown that βˆ is root-n consistent, the
data-adaptive weight θj = |βˆSj |−1 has the order of n1/2. When
√
nλn → 0,√
nan =
√
nλnθ → 0 and bn = 0. Hence Condition A.4 is satisfied. For regu-
larly stratified data, when nkλn →∞, lim
nk→∞
√
nk inf
||β||≤Cn−1/2
p′λn(|β|) =
√
nkλnθ =
nkπ
1/2
k λn →∞. For highly stratified data, whenKλn →∞, lim
K→∞
mK1/2 inf
||β||≤Cn−1/2
p′λn(|β|) =
m3/2Kλn →∞. Condition A.5 is satisfied.
(b). SCAD: when λn → 0, an = bn = 0. Condition A.4 is satisfied. For regular strat-
ified data, When
√
nkλn →∞, lim
nk→∞
√
nk inf
||β||≤Cn−1/2
p′λn(|β|) =
√
nkλn →∞; for
highly-stratified data, when K1/2λn →∞, lim
K→∞
mK1/2 inf
||β||≤Cn−1/2
p′λn(|β|) =
mK1/2λn →∞. Condition A.5 holds.
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(c). MCP: when λn → 0, an = bn = 0 for sufficiently large n. Condition A.4 is satis-
fied. For regularly stratified data, when
√
nkλn →∞, √nk inf
||β||≤Cn−1/2
p′λn(|β|) =
√
nkλn − C√πk/γ →∞. For highly stratified data, when K1/2λn →∞,
mK1/2 inf
||β||≤Cn−1/2
p′λn(|β|) = mK1/2λn − Cm1/2/γ →∞. Condition A.5 holds.
Hence, according to Theorem 1 and Theorem 2, when λn is chosen appropriately,
the three penalized estimators possess the oracle properties under both stratification
regimes and asymptotically follow a normal distribution
√
n(β˜
S
1r − β01) → N(0,
(
∑K
k=1 πkΩ11k)
−1(
∑K
k=1 πkΣ11k)(
∑K
k=1 πkΩ11k)
−1) when data are regularly stratified,
and follow
√
n(β˜
S
1h − β01)→ N(0,Ω−111 m−1Σ11Ω−111 ) when data are highly stratified.
For LASSO, the oracle properties do not hold. From Condition A.4, an = λn =
Op(n
−1/2) and bn = 0, whereas Condition A.5 requires that n
1/2
k λn = π
1/2
k n
1/2λ→∞
for regularly stratified data and m1/2n1/2λn →∞ for highly stratified data. The two
conditions can not be simultaneously held.
Appendix B Large Sample Properties of the Pe-
nalized Marginal PSH Model
We assume the following regularity conditions
B1.
∫ τ
0
λ10(t)dt <∞
B2. Define
s(p)(β, t) = lim
K→∞
K−1
K∑
k=1
nk∑
i=1
I(Cki ≥ t)Yki(t)Z⊗pki exp(βTZki) (52)
S(p)(β, t) = K−1
K∑
k=1
nk∑
i=1
I(Cki ≥ t)Yki(t)Z⊗pki exp(βTZki) (53)
Sˆ(p)(β, t) = K−1
K∑
k=1
nk∑
i=1
wˆki(t)Yki(t)Z
⊗p
ki exp(β
TZki) (54)
There exits a neighborhood B of β0 such that the following conditions are sat-
isfied: (i) there exits a scalar, a vector, and a matrix function s(0), s(1), and s(2)
defined on B × [0, τ ] such that supt∈[0,τ ],β∈B‖S(p)(β, t)− s(p)(β, t)‖ → 0 in prob-
ability, p = 0, 1, 2; (ii). the matrix ΩM =
∫ τ
0
v(β0, t)s
(0)(β0, t)λ10(t)dt is positive
definite, where v = s(2)/s(0) − (s(1)/s(0))(s(1)/s(0))T .
B3. s(p)(β, t) are continuous functions of β ∈ B uniformly in t ∈ [0.τ ] and are bounded
on B × [0, τ ], s(0)(β, t) is bounded away from zero.
B4. The penalty function satisfies that aK = Op(K
−1/2) and bK → 0.
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B5. pλn(|β|) satisfies lim
K→∞
K1/2 inf
|β|≤CK−1/2
p′λK (|β|)→∞.
The following theorem states selection consistency and the oracle properties of the
penalization methods for the marginal PSH model.
Theorem 3. Under Condition B.1 - B.4 in the Appendix, the following holds as
K →∞,
a. β˜
M
is a root-K consistent estimator for β0, i.e. ||β˜
M − β0|| = Op(K−1/2).
b. (Oracle properties) With probability tending to 1, the root-K consistent estima-
tor β˜ satisfies
i. (Sparsity) β˜
M
2 = 0
ii. (Asymptotic normality) K1/2(ΩM11 +P11){β˜
M
1 −β01+(ΩM11 +P11)−1b1} →
N(0,ΣM11(β0)), where Ω
M
11 and Σ
M
11 are the first s×s submatrix of ΩM(β0)
and ΣM(β0), defined in the Appendix.
B.1 Proof of Theorem 3.a.
It is sufficient to prove that for any positive ǫ, there exists a large constant C such
that
Pr{ sup
‖u‖=C
QM(β0 + αKu) < Q
M(β0)} ≥ 1− ǫ (55)
where αK = K
−1/2 + aK . Denote DK(u) =
1
K
{QC(β0 + αKu)−QC(β0)}, and
DK(u) ≤ 1
K
lM(β0 + αKu)− lM (β0)} −
s∑
j=1
{pλK (|βj0 + αKuj|)− pλK (|βj0|)} (56)
By Taylor expansion, the first part
I1 =
1
K
(
∂lM (β0)
∂β
)TαKu− 1
2
uT {− 1
K
∂2lM(β0)
∂βT∂β
+ op(1)}uα2K (57)
= Op(α
2
KC) +Op(α
2
KC
2) (58)
From Section A.1.1, term I2 has the order of Cα
2
K if bK → 0. By choosing a sufficiently
large C, Op(C
2α2K) dominates the others. Thus inequality(55) holds.
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B.2 Proof of Theorem 3.b.(i)
Define the following process
X(β, τ) =
1
K
{lM (β)− lM (β0)} (59)
=
1
K
K∑
k=1
nk∑
i=1
∫ τ
0
{(β − β0)TZki − log
Sˆ(0)(β, u)
Sˆ(0)(β0, u)
}wˆki(u)dNki(u) (60)
A(β, τ) =
1
K
K∑
k=1
nk∑
i=1
∫ τ
0
{(β − β0)TZki − log
Sˆ(0)(β, u)
Sˆ(0)(β0, u)
}wˆki(u)λ1(u)du (61)
=
∫ τ
0
{(β − β0)T Sˆ(1)(β0, u)− Sˆ(0)(β0, u) log
Sˆ(0)(β, u)
Sˆ(0)(β0, u)
}λ10(u)du (62)
From Zhou et al (2012), we haveX(β, .)−A(β, .)→ 0 in probability and limK→∞ Sˆ(p)(β, t) =
G(t)s(p)(β, t). Thus for each β ∈ B,
A(β, τ)→ f(β, τ) =
∫ τ
0
{(β − β0)T s(1)(β0, u)− s(0)(β0, u) log
s(0)(β, u)
s(0)(β0, u)
}λ10(u)du
(63)
where f has the following properties
f(β0) = 0,
∂f(β0)
∂β
= 0, −∂
2f(β0)
∂β∂βT
= ΩM(β0) (64)
Then the following holds
1
K
{lM (β)− lM (β0)} = f(β, τ) +Op(
||β − β0||√
K
) (65)
We also have f(β) = −1
2
(β − β0)T{Ω(β0) + op(1)}(β − β0). By Taylor expansion,
we obtain
∂QM (β)
∂βj
=
∂lM (β)
∂βj
−Kp′λK (|βj|)sgn(βj) (66)
= K
d∑
l=1
∂2f(β0)
∂βj∂βl
(βl − βl0) +Op(K1/2||β − β0||)−Kp′λK (|βj|)sgn(βj)
(67)
= Op(K
1/2) +Op(1)−Kp′λn(|βj|)sgn(βj) (68)
= K1/2{Op(1)−K1/2p′λn(|βj|)sgn(βj)} (69)
Since lim
K→∞
K1/2 inf
||β||≤CK−1/2
p′λK (|β|) → ∞, k = 1, . . . , K, the sign of
∂QC(β)
βj
is com-
pletely determined by the sign of βj .
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B.3 Proof of Theorem 3.b. (ii)
It is easy to show that there exists a root-n consistent local maximizer β˜1 of Q(β1, 0),
satisfying equation
∂QM (β)
∂β1
∣∣∣
β=(β˜
T
1 ,0)
T
= 0. Denote UM(β) and HM(β) as the score function and the
Hessian matrix of lM (β) and it is
UM (β) =
K∑
k=1
nk∑
i=1
∫ ∞
0
{Zik − Sˆ
(1)(β, u)
Sˆ(0)(β, u)
}wˆik(u)dNik(u) (70)
HM(β) =
K∑
k=1
nk∑
i=1
∫ ∞
0
[
Sˆ(2)(β, u)
Sˆ(0)(β, u)
− { Sˆ
(1)(β, u)
Sˆ(0)(β, u)
}⊗2
]
wˆik(u)dNik(u) (71)
For j = 1, . . . , s
0 =
∂lM (β)
∂βj
∣∣∣
β=(β˜
T
1 ,0)
T
−Kp′λn(|β˜j |)sgn(β˜j)
=
∂lM (β0)
∂βj
−
s∑
l=1
{−∂
2f(β0)
∂βj∂βl
+ op(1)}(β˜l − βl0)−
K
(
p′λK (|βj0|)sgn(βj0) + {p′′λK (|βj0|) + op(1)}(β˜j − βj0)
)
(72)
Denote UM11 (β) as the first s elements of the score function U
M (β). As K → ∞,
K−1/2UM11 (β0)→ N(0,ΣM11(β0)) in distribution, where ΣM11 is the first s×s submatrix
of ΣM . Furthermore, let HM11 be the first s× s submatrix of of HM and −
1
K
HM11 →
ΩM11(β0) in probability, where Ω
M
11 is the first s× s submatrix of ΩM . Let b1 be the
first s elements of b, and P11 be the first s×s submatrix of P. By Slutsky’s Theorem,
K1/2(ΩM11 +P11){β˜1 − β01 + (ΩM11 +P11)−1b1} → N(0,ΣM11(β0)) (73)
This completes the proof.
To achieve the oracle properties, penalty functions need satisfy Condition B.3 −
B.4. Borrowing the arguments in Section (A.3), we can easily show that the oracle
properties of ALASSO, SCAD, and MCP hold when λ is chosen appropriately: (a).
ALASSO possesses the oracle properties when
√
KλK → 0, KλK → ∞, and θj =
|βˆMj |−1, where |βˆ
M
j |−1 is the maximizer of the pseudopartial likelihood with root-K
consistency; (b). SCAD and MCP have the oracle properties when λK → 0 and√
KλK →∞; (c). the oracle properties do not hold for LASSO.
Appendix C Complete Selection Results in the UNOS
Data Analysis
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Table 8: Complete Variable selection results and estimated regression coefficients using UNOS data.
Regularly Stratified Highly Stratified Marginal
KDRI LASSO ALASSO SCAD MCP LASSO ALASSO SCAD MCP LASSO ALASSO SCAD MCP
Donor Factors
Age -40 yrs 0.013(0.002) 0.012(0.001) 0.013(0.001) 0.013(0.001) 0.012(0.001) 0.011(0.001) 0.013(0.001) 0.013(0.001) 0.012(0.001) 0.012(0.001) 0.013(0.001) 0.012(0.001) 0.012(0.001)
(applies to all ages)
Age -18 yrs -0.019(0.010) -0.01(0.008) -0.013(0.006) -0.005(0.007) -0.005(0.007) -0.015(0.006) -0.014(0.005) -0.005(0.005) -0.005(0.005) -0.014(0.008) -0.018(0.007) -0.014(0.008) -0.014(0.008)
(applies only if age<18)
Age -50 yrs 0.011(0.006) 0.020(0.003) 0.018(0.003) 0.018(0.003) 0.019(0.003) 0.018(0.003) 0.016(0.002) 0.018(0.002) 0.019(0.002) 0.020(0.003) 0.018(0.003) 0.020(0.003) 0.020(0.003)
(applies only if age>50)
Afrian American race 0.179(0.071) 0.170(0.031) 0.167(0.031) 0.172(0.031) 0.168(0.031) 0.151(0.023) 0.148(0.027) 0.174(0.026) 0.169(0.027) 0.164(0.033) 0.157(0.033) 0.166(0.033) 0.166(0.033)
Male - -0.037(0.026) - - - -0.042(0.018) - - - -0.035(0.026) -0.027(0.023) -0.034(0.026) -0.034(0.026)
Height: per 10 cm increase -0.046(0.015) -0.021(0.013) -0.031(0.011) -0.029(0.011) -0.008(0.01) -0.031(0.008) -0.028(0.009) -0.018(0.014) - -0.019(0.014) -0.019(0.014)
Weight -0.020(0.010) -0.227(0.06) -0.311(0.052) -0.248(0.059) -0.241(0.059) -0.169(0.048) -0.215(0.043) -0.251(0.05) -0.244(0.045) -0.213(0.064) -0.235(0.059) -0.220(0.064) -0.220(0.064)
(per 5 kg increase if <80 kg)
Donation after cardiac death 0.133(0.132) - - - - - - - - - - - -
Cause of death: stroke 0.088(0.051) 0.061(0.025) 0.073(0.024) - 0.067(0.024) 0.067(0.021) 0.040(0.019) - 0.069(0.022) 0.066(0.025) 0.053(0.025) 0.066(0.025) 0.066(0.025)
Serum creatinine-1 0.220(0.051) 0.195(0.036) 0.174(0.035) 0.183(0.035) 0.186(0.035) 0.150(0.026) 0.107(0.028) 0.183(0.022) 0.187(0.029) 0.192(0.035) 0.155(0.035) 0.196(0.035) 0.196(0.035)
(applies to all Cr values )
Serum creatinine-1 -0.209(0.082) -0.189(0.05) -0.165(0.049) -0.176(0.049) -0.179(0.049) -0.143(0.034) -0.099(0.036) -0.177(0.032) -0.18(0.036) -0.185(0.046) -0.148(0.046) -0.189(0.046) -0.189(0.046)
(applies if Cr>1.5 )
Diabetic 0.130(0.076) 0.233(0.047) 0.237(0.047) 0.228(0.047) 0.232(0.047) 0.212(0.039) 0.191(0.038) 0.231(0.034) 0.235(0.036) 0.242(0.05) 0.229(0.049) 0.245(0.05) 0.245(0.05)
Hypertensive 0.126(0.102) 0.137(0.026) 0.139(0.026) 0.151(0.026) 0.138(0.026) 0.132(0.02) 0.130(0.021) 0.15(0.018) 0.136(0.022) 0.142(0.027) 0.143(0.027) 0.142(0.027) 0.142(0.027)
Cigarette users - 0.027(0.021) - - - 0.017(0.013) - - - 0.024(0.018) - 0.025(0.018) 0.025(0.018)
Positive HCV status 0.240(0.153) 0.098(0.068) - - - 0.070(0.048) - - - 0.133(0.064) 0.055(0.064) 0.135(0.064) 0.135(0.064)
Transplant Factors
Cold ischemic time 0.005(0.003) 0.003(0.001) - - - 0.002(0.001) - - - 0.004(0.002) 0.002(0.001) 0.004(0.002) 0.004(0.002)
( per 1 hr (ref=20 hr) )
Organ sharing
Regional(ref=local) - 0.061(0.037) - - - 0.045(0.022) - - - 0.030(0.038) - 0.031(0.038) 0.031(0.038)
National(ref=local) - -0.052(0.031) - - - -0.038(0.027) - - - -0.049(0.037) - -0.051(0.037) -0.051(0.037)
HLA-B mismatch
0 (ref=2 B MM) -0.077(0.056) -0.155(0.034) -0.176(0.031) -0.174(0.031) -0.174(0.031) -0.141(0.028) -0.134(0.025) -0.174(0.027) -0.174(0.03) -0.154(0.039) -0.158(0.039) -0.156(0.039) -0.156(0.039)
1 -0.061(0.041) -0.068(0.023) -0.07(0.023) -0.069(0.023) -0.069(0.023) -0.057(0.019) -0.051(0.021) -0.067(0.018) -0.067(0.017) -0.055(0.025) -0.052(0.024) -0.056(0.025) -0.056(0.025)
HLA-DR mismatch
0 (ref=1 DR MM) -0.130(0.041) -0.097(0.027) -0.103(0.027) -0.102(0.027) -0.102(0.027) -0.087(0.024) -0.078(0.02) -0.102(0.024) -0.102(0.023) -0.091(0.03) -0.084(0.029) -0.092(0.03) -0.092(0.03)
2 0.077(0.051) 0.055(0.023) 0.057(0.023) 0.058(0.023) 0.057(0.023) 0.051(0.018) 0.047(0.019) 0.058(0.017) 0.057(0.02) 0.063(0.025) 0.058(0.025) 0.063(0.025) 0.063(0.025)
Transplant year - -0.155(0.021) -0.161(0.021) -0.165(0.021) -0.163(0.021) -0.139(0.018) -0.139(0.021) -0.166(0.02) -0.164(0.02) -0.151(0.025) -0.156(0.025) -0.152(0.025) -0.151(0.025)
En bloc transplant -0.346(0.138) -0.313(0.117) -0.285(0.116) -0.317(0.117) -0.312(0.117) -0.209(0.094) -0.083(0.085) -0.310(0.094) -0.304(0.081) -0.295(0.124) -0.132(0.122) -0.304(0.124) -0.304(0.124)
Double kidney transplant -0.148(0.22) -0.334(0.093) -0.329(0.092) -0.332(0.092) -0.33(0.092) -0.247(0.063) -0.181(0.047) -0.331(0.067) -0.330(0.061) -0.329(0.078) -0.250(0.078) -0.338(0.078) -0.338(0.078)
ABO identical - - - - - - - - - -0.023(0.052) - -0.026(0.052) -0.027(0.052)
Recipient Factors
Age -0.025(0.001) -0.025(0.001) -0.025(0.001) -0.025(0.001) -0.024(0.001) -0.025(0.001) -0.025(0.001) -0.025(0.001) -0.025(0.001) -0.025(0.001) -0.025(0.001) -0.025(0.001)
African America 0.356(0.025) 0.359(0.025) 0.363(0.024) 0.363(0.024) 0.362(0.02) 0.386(0.02) 0.364(0.02) 0.364(0.019) 0.372(0.027) 0.384(0.028) 0.371(0.027) 0.371(0.027)
Male -0.049(0.022) -0.053(0.022) - - -0.032(0.017) -0.018(0.015) - - -0.06(0.026) -0.039(0.021) -0.063(0.026) -0.063(0.026)
Primary diagnosis (ref=GN)
Diabetes -0.075(0.03) -0.080(0.03) -0.079(0.03) -0.079(0.03) -0.063(0.023) -0.053(0.023) -0.074(0.023) -0.074(0.026) -0.059(0.033) -0.054(0.033) -0.060(0.033) -0.060(0.033)
Hypertension 0.102(0.029) 0.100(0.029) 0.098(0.029) 0.097(0.029) 0.088(0.02) 0.074(0.021) 0.101(0.019) 0.101(0.021) 0.119(0.028) 0.109(0.028) 0.121(0.028) 0.121(0.028)
Failed transplants 0.545(0.142) 0.546(0.142) 0.538(0.142) 0.539(0.142) 0.479(0.116) 0.432(0.096) 0.540(0.094) 0.542(0.109) 0.561(0.141) 0.522(0.141) 0.570(0.141) 0.570(0.141)
CAKUT/Congenital uropathy -0.191(0.038) -0.193(0.038) -0.191(0.038) -0.192(0.038) -0.164(0.03) -0.136(0.03) -0.194(0.029) -0.194(0.029) -0.197(0.04) -0.179(0.039) -0.200(0.04) -0.200(0.04)
Others 0.048(0.032) 0.051(0.032) 0.057(0.032) 0.057(0.032) 0.045(0.032) 0.044(0.025) 0.061(0.023) 0.061(0.027) 0.072(0.037) 0.072(0.037) 0.073(0.037) 0.073(0.037)
Blood transfusion 0.040(0.022) - - - 0.034(0.017) - - - 0.032(0.023) - 0.033(0.023) 0.033(0.023)
Height - - - - - - - - 0.001(0.001) - 0.001(0.001) 0.001(0.001)
Weight 0.005(0.001) 0.005(0.001) 0.005(0.001) 0.005(0.001) 0.004(0.0005) 0.004(0.001) 0.005(0.0005) 0.005(0.0005) 0.005(0.001) 0.005(0.001) 0.005(0.001) 0.005(0.001)
Peak PRA (ref=0)
1-50 0.057(0.023) 0.057(0.023) 0.060(0.023) 0.061(0.023) 0.044(0.015) 0.029(0.019) 0.060(0.02) 0.061(0.017) 0.037(0.024) 0.031(0.024) 0.038(0.024) 0.038(0.024)
51-80 0.116(0.057) 0.119(0.057) 0.138(0.057) 0.137(0.057) 0.095(0.048) 0.066(0.047) 0.142(0.047) 0.141(0.048) 0.096(0.06) 0.081(0.06) 0.098(0.06) 0.098(0.06)
>80 0.244(0.048) 0.246(0.047) 0.268(0.047) 0.267(0.047) 0.196(0.035) 0.134(0.036) 0.269(0.037) 0.268(0.034) 0.231(0.049) 0.194(0.049) 0.236(0.049) 0.236(0.049)
Years of RRT (ref: <=1)
2-3 - - - - - - - - -0.013(0.022) -0.004(0.022) -0.015(0.022) -0.015(0.022)
>3 - - - - - - - - -0.031(0.028) -0.010(0.027) -0.035(0.028) -0.035(0.028)
Angina pectoris -0.059(0.035) - - - -0.041(0.026) -0.048(0.035) -0.034(0.035) -0.050(0.035) -0.050(0.035)
Peripheral vascular disease - - - - - - - - - - - -
COPD - - - - - - - - -0.085(0.115) - -0.092(0.115) -0.092(0.115)
Positive HCV status 0.207(0.044) 0.242(0.037) 0.237(0.037) 0.238(0.037) 0.196(0.035) 0.208(0.032) 0.237(0.026) 0.237(0.029) 0.195(0.043) 0.204(0.043) 0.197(0.043) 0.197(0.043)
Diabetic - - - - - - - - - - - -
HCV: Hepatitis C. Cr: serum creatinine. HLA: human leukocyte antigen. GN: glomerulonephritis CAKUT: congenital anomalies of the kidney and urinary tract. RRT: renal replacement therapy COPD: chronic obstructive
pulmonary disease.
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Appendix D Simulations Results for Dependent Cen-
soring
We consider three scenarios when censoring times and covariates are dependent. In
Scenario (a), we allowed the censoring to depend on important variables z1 and z4;
in Scenario (b), censoring times depend on non-important variables z5 and z8; in
Scenario (c), censoring times depend on both important and non-important variables
z1 and z3; in Scenario (d), we displayed the results when censoring and covariates are
independent.
D.1 Penalized Stratified PSH Model
D.1.1 Regularly Stratified
Table 9: Selection results of the penalized stratified based on 100 replications with
different censoring patterns, where K = 3, n = 200, p = 0.6, the censoring rate is
28%, and the event rate is 45%
Scenario Depend on Penalty C (5) IC (0) Pcorr MMSE
(a) z1, z4 MPLE 0 0 0% 0.137
LASSO 3.43 0 20% 0.166
ALASSO 4.73 0.02 76% 0.086
SCAD 4.89 0.03 90% 0.053
MCP 4.90 0.02 90% 0.052
Oracle 5 0 100% 0.050
(b) z5, z8 MPLE 0 0 0% 0.143
LASSO 3.64 0.01 21% 0.125
ALASSO 4.79 0.03 78% 0.084
SCAD 4.89 0.02 87% 0.059
MCP 4.92 0.02 90% 0.056
Oracle 5 0 100% 0.051
(c) z1, z3 MPLE 0 0 0% 0.134
LASSO 3.54 0 23% 0.148
ALASSO 4.79 0.02 81% 0.083
SCAD 4.88 0.02 89% 0.056
MCP 4.90 0.02 91% 0.054
Oracle 5 0 100% 0.050
(d) Independent MPLE 0 0 0% 0.133
LASSO 3.37 0 23% 0.112
ALASSO 4.75 0.01 79% 0.064
SCAD 4.92 0 92% 0.052
MCP 4.92 0 92% 0.056
Oracle 5 0 100% 0.044
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D.1.2 Highly Stratified
Table 10: Selection results of the penalized stratified model based on 100 replications
with different censoring patterns, where α1 = 0.7, K = 100, nk ∈ {2, 3, 4, 5}. The
censoring rate is 27% and the event rate is 46%.
Scenario Depend on Penalty C (5) IC (0) Pcorr MMSE
(a) z1, z4 MPLE 0 0 0% 0.168
LASSO 3.60 0.01 20% 0.200
ALASSO 4.82 0.04 81% 0.113
SCAD 4.92 0.09 85% 0.070
MCP 4.91 0.09 86% 0.070
Oracle 5 0 100% 0.066
(b) z5, z8 MPLE 0 0 0% 0.167
LASSO 3.73 0.01 26% 0.199
ALASSO 4.76 0.04 77% 0.124
SCAD 4.88 0.11 83% 0.070
MCP 4.88 0.13 83% 0.070
Oracle 5 0 100% 0.063
(c) z1, z3 MPLE 0 0 0% 0.174
LASSO 3.59 0.01 29% 0.185
ALASSO 4.73 0.06 75% 0.112
SCAD 4.92 0.10 86% 0.069
MCP 4.93 0.10 85% 0.069
Oracle 5 0 100% 0.065
(d) Independent MPLE 0 0 0% 0.164
LASSO 3.61 0 22% 0.178
ALASSO 4.76 0.02 79% 0.097
SCAD 4.90 0.06 88% 0.060
MCP 4.90 0.05 87% 0.060
Oracle 5 0 100% 0.058
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D.2 Penalized Marginal PSH Model
Table 11: Selection results of the penalized marginal model based on 100 replications
with different censoring patterns, where α1 = 0.7, K = 100, nk ∈ {2, 3, 4, 5}. The
censoring rate is 29% and the event rate is 43%.
Scenario Depend on Penalty C (5) IC (0) Pcorr MMSE
(a) z1, z4 MPLE 0 0 0% 0.101
LASSO 3.36 0 15% 0.065
ALASSO 4.77 0 83% 0.039
SCAD 4.82 0 86% 0.034
MCP 4.81 0 86% 0.033
Oracle 5 0 100% 0.031
(b) z5, z8 MPLE 0 0 0% 0.108
LASSO 3.64 0 29% 0.067
ALASSO 4.75 0 82% 0.033
SCAD 4.80 0 86% 0.032
MCP 4.83 0 87% 0.033
Oracle 5 0 100% 0.031
(c) z1, z3 MPLE 0 0 0% 0.104
LASSO 3.58 0 22% 0.071
ALASSO 4.80 0 84% 0.038
SCAD 4.83 0 88% 0.034
MCP 4.84 0 88% 0.034
Oracle 5 0 100% 0.032
(d) Independent MPLE 0 0 0% 0.097
LASSO 3.56 0 22% 0.060
ALASSO 4.84 0 85% 0.035
SCAD 4.88 0 91% 0.031
MCP 4.84 0 85% 0.032
Oracle 5 0 100% 0.029
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